scholarly article | Q13442814 |
P50 | author | Yann Grosse | Q63681468 |
Kurt Straif | Q63701596 | ||
Lamia Benbrahim-Tallaa | Q52563483 | ||
Neela Guha | Q54263882 | ||
Béatrice Lauby-Secretan | Q56816033 | ||
P2093 | author name string | Freeman C | |
Bouvard V | |||
Baan R | |||
Guha N | |||
Cogliano V | |||
El Ghissassi F | |||
Galichet L | |||
P2860 | cites work | Classification of papillomaviruses | Q29618731 |
Antibodies against human herpesvirus 8 in black South African patients with cancer. | Q33864971 | ||
Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults | Q33925343 | ||
Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts | Q34340678 | ||
Helicobacter pylori and esophageal cancer risk: a meta-analysis | Q36410246 | ||
Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma | Q37212310 | ||
The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda | Q38883642 | ||
Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A. | Q40006257 | ||
Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection | Q43038794 | ||
Genetic and environmental determinants of risk for cholangiocarcinoma via Opisthorchis viverrini in a densely infested area in Nakhon Phanom, northeast Thailand | Q46547825 | ||
Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. | Q54638403 | ||
Cholangiocarcinoma and Clonorchis sinensis infection: a case-control study in Korea | Q57212941 | ||
A review of human carcinogens—Part A: pharmaceuticals | Q58006583 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 321-2 | |
P577 | publication date | 2009-04-01 | |
P1433 | published in | Lancet Oncology Commission | Q13747613 |
P1476 | title | A review of human carcinogens--Part B: biological agents | |
P478 | volume | 10 |
Q40196443 | 5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression |
Q38586257 | 9-Valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV. |
Q49687633 | 9-Valent human papillomavirus vaccine: a review of the clinical development program. |
Q36734588 | A Community-Based Approach to Enhancing Anal Cancer Screening in Hawaii's HIV-Infected Ethnic Minorities |
Q38780225 | A Comparison of the Natural History of HPV Infection and Cervical Abnormalities among HIV-Positive and HIV-Negative Women in Senegal, Africa |
Q36169189 | A Low-Cost HPV Immunochromatographic Assay to Detect High-Grade Cervical Intraepithelial Neoplasia |
Q36407125 | A Suggested Approach to Simplify and Improve Cervical Screening in the United States |
Q86927860 | A Viable and Simple Self-Sampling Method for Human Papillomavirus Detection among South African Adolescents |
Q59357534 | A bacterial genotoxin causes virus reactivation and genomic instability in Epstein-Barr virus infected epithelial cells pointing to a role of co-infection in viral oncogenesis |
Q38378838 | A cohort study of cervical screening using partial HPV typing and cytology triage |
Q34442596 | A combination of the Kato-Katz methods and ELISA to improve the diagnosis of clonorchiasis in an endemic area, China |
Q36514226 | A comparison of human papillomavirus genotype-specific DNA and E6/E7 mRNA detection to identify anal precancer among HIV-infected men who have sex with men. |
Q35671337 | A cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil |
Q34580264 | A cross-sectional study to estimate high-risk human papillomavirus prevalence and type distribution in Italian women aged 18-26 years |
Q61774978 | A cyclin-binding motif in human papillomavirus type 18 (HPV18) E1^E4 is necessary for association with CDK-cyclin complexes and G2/M cell cycle arrest of keratinocytes, but is not required for differentiation-dependent viral genome amplification or L |
Q41715956 | A high and increasing HPV prevalence in tonsillar cancers in Eastern Denmark, 2000-2010: the largest registry-based study to date |
Q34153680 | A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection |
Q35164373 | A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study |
Q35630020 | A million africans a year dying from cancer by 2030: what can cancer research and control offer to the continent? |
Q39236598 | A mutagenesis method for the addition and deletion of highly repetitive DNA regions: the paradigm of EPIYA motifs in the cagA gene of Helicobacter pylori |
Q40458264 | A naturally occurring variant of HPV-16 E7 exerts increased transforming activity through acquisition of an additional phospho-acceptor site. |
Q64076777 | A novel sequencing-based vaginal health assay combining self-sampling, HPV detection and genotyping, STI detection, and vaginal microbiome analysis |
Q33793914 | A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia |
Q35154570 | A prime/boost strategy using DNA/fowlpox recombinants expressing the genetically attenuated E6 protein as a putative vaccine against HPV-16-associated cancers. |
Q34708325 | A randomized, observer-blinded immunogenicity trial of Cervarix(®) and Gardasil(®) Human Papillomavirus vaccines in 12-15 year old girls |
Q36427451 | A review of methods for detect human Papillomavirus infection |
Q36016617 | A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results |
Q41524569 | A systematic investigation of the contribution of genetic variation within the MHC region to HPV seropositivity |
Q30368719 | A tegument-specific venom allergen-like protein of Clonorchis sinensis. |
Q92369502 | A virome-wide clonal integration analysis platform for discovering cancer viral etiology |
Q27346723 | AACR Cancer Progress Report 2014 |
Q37210896 | AACR Cancer Progress Report 2015 |
Q47150003 | Acceptability of Human Papillomavirus Self-Sampling for Cervical Cancer Screening in an Indigenous Community in Guatemala |
Q37275408 | Accuracy of the Kato-Katz method and formalin-ether concentration technique for the diagnosis of Clonorchis sinensis, and implication for assessing drug efficacy |
Q42146528 | Acetylation of intragenic histones on HPV16 correlates with enhanced HPV16 gene expression |
Q38863335 | Addressing the Barriers to Cervical Cancer Prevention Among Hispanic Women |
Q28544831 | Advanced enzymology, expression profile and immune response of Clonorchis sinensis hexokinase show its application potential for prevention and control of clonorchiasis |
Q35039759 | Age-stratified 5-year risks of cervical precancer among women with enrollment and newly detected HPV infection |
Q35858231 | Alcohol Drinking Obliterates the Inverse Association Between Serum Retinol and Risk of Head and Neck Cancer |
Q34577067 | Allergies and risk of head and neck cancer: an original study plus meta-analysis |
Q38947049 | An EF-handed Ca(2+)-binding protein of Chinese liver fluke Clonorchis sinensis |
Q64386288 | An Observational Study of Deep Learning and Automated Evaluation of Cervical Images for Cancer Screening |
Q37180056 | An analysis of HPV infection incidence and clearance by genotype and age in men: The HPV Infection in Men (HIM) Study |
Q27014019 | An updated overview of HPV-associated head and neck carcinomas |
Q40126055 | Anal HPV 16 and 18 viral load: a comparison between HIV-negative and HIV-positive MSM and association with persistence |
Q89430566 | Anal HPV infection and correlates in HIV-infected patients attending a Sexually Transmitted Infection clinic in Brazil |
Q37996691 | Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis |
Q92446826 | Analysis of Human Papillomavirus (HPV) 16 Variants Associated with Cervical Infection in Italian Women |
Q38754272 | Analysis of Multiple HPV E6 PDZ Interactions Defines Type-Specific PDZ Fingerprints That Predict Oncogenic Potential |
Q90865025 | Analytical performance evaluation of the HPV OncoCheck assay for detection of high-risk HPV infection in liquid-based cervical samples |
Q47727139 | Angiogenesis in Schistosoma haematobium-associated urinary bladder cancer |
Q30534669 | Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels |
Q47134134 | Anogenital Human Papillomavirus Infection and HIV Infection Outcomes Among Peruvian Transgender Women: Results from a Cohort Study |
Q26777623 | Antibiotic treatment for Helicobacter pylori: Is the end coming? |
Q35623269 | Antibodies against lytic and latent Kaposi's sarcoma-associated herpes virus antigens and lymphoma in the European EpiLymph case-control study |
Q60947009 | Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis |
Q44320296 | Application of a loop-mediated isothermal amplification (LAMP) assay targeting cox1 gene for the detection of Clonorchis sinensis in human fecal samples |
Q34596772 | Aptima HPV E6/E7 mRNA test is as sensitive as Hybrid Capture 2 Assay but more specific at detecting cervical precancer and cancer |
Q41153416 | Are male immigrants in Denmark at lower or higher risk of tobacco-related cancers? A Danish nationwide cohort study |
Q40727294 | Assessing Acceptability of Self-Sampling Kits, Prevalence, and Risk Factors for Human Papillomavirus Infection in American Indian Women |
Q98183610 | Assessment of attribution algorithms for resolving CIN3-related HPV genotype prevalence in mixed-genotype biopsy specimens using laser capture microdissection as the reference standard |
Q90696421 | Assessment of control strategies against Clonorchis sinensis infection based on a multi-group dynamic transmission model |
Q52631128 | Assessment of viral methylation levels for high risk HPV types by newly designed consensus primers PCR and pyrosequencing. |
Q36904250 | Association Between Cumulative Psychosocial Risk and Cervical Human Papillomavirus Infection Among Female Adolescents in a Free Vaccination Program |
Q41294071 | Association Between Educational Level and Risk of Cancer in HIV-infected Individuals and the Background Population: Population-based Cohort Study 1995-2011. |
Q39974039 | Association Between Serum 25-Hydroxyvitamin D Level and Human Papillomavirus Cervicovaginal Infection in Women in the United States |
Q37570000 | Association Between Type-specific HPV Infections and hTERT DNA Methylation in Patients with Invasive Cervical Cancer. |
Q91708310 | Association Study Between Methylation in the Promoter Regions of cGAS, MAVS, and TRAF3 Genes and the Risk of Cervical Precancerous Lesions and Cervical Cancer in a Southern Chinese Population |
Q42374973 | Association between four SNPs in IL-4 and the risk of gastric cancer in a Chinese population |
Q35203345 | Association between free testosterone levels and anal human papillomavirus types 16/18 infections in a cohort of men who have sex with men |
Q36253519 | Association between hTERT activation by HPV E6 proteins and oncogenic risk |
Q35328464 | Association between malaria exposure and Kaposi's sarcoma-associated herpes virus seropositivity in Uganda |
Q88585888 | Association between the XPG gene rs2094258 polymorphism and risk of gastric cancer |
Q37524425 | Association of Chlamydia trachomatis infection and herpes simplex virus type 2 serostatus with genital human papillomavirus infection in men: the HPV in men study |
Q33526682 | Association of HIV infection with distribution and viral load of HPV types in Kenya: a survey with 820 female sex workers |
Q36405118 | Association of HIV viral load and CD4 cell count with human papillomavirus detection and clearance in HIV-infected women initiating highly active antiretroviral therapy |
Q26782217 | Association of Lymphomagenesis and the Reactivation of Hepatitis B Virus in Non-Hodgkin Lymphoma |
Q41487050 | Association of human papillomavirus type 58 with breast cancer in Shaanxi province of China |
Q37077419 | Association of human papillomavirus, Neisseria gonorrhoeae and Chlamydia trachomatis co-infections on the risk of high-grade squamous intraepithelial cervical lesion |
Q52665346 | Association of marijuana use with oral HPV infection and periodontitis among Hispanic adults: Implications for oral cancer prevention. |
Q36319807 | Associations of Human Papillomavirus (HPV) genotypes with high-grade cervical neoplasia (CIN2+) in a cohort of women living with HIV in Burkina Faso and South Africa |
Q54363768 | Associations of human leukocyte antigen class II genotypes with human papillomavirus 18 infection and cervical intraepithelial neoplasia risk. |
Q37838503 | Asymptomatic anal sexually transmitted infections in HIV-positive men attending anal cancer screening |
Q30746365 | Autonomous portable solar ultraviolet spectroradiometer (APSUS) - a new CCD spectrometer system for localized, real-time solar ultraviolet (280-400 nm) radiation measurement |
Q37430038 | Awareness and knowledge of Human Papillomavirus (HPV), HPV-related cancers, and HPV vaccines in an uninsured adult clinic population |
Q28554487 | Azidothymidine Sensitizes Primary Effusion Lymphoma Cells to Kaposi Sarcoma-Associated Herpesvirus-Specific CD4+ T Cell Control and Inhibits vIRF3 Function |
Q33798426 | BALB/c mice immunized with a combination of virus-like particles incorporating Kaposi sarcoma-associated herpesvirus (KSHV) envelope glycoproteins gpK8.1, gB, and gH/gL induced comparable serum neutralizing antibody activity to UV-inactivated KSHV. |
Q35571682 | Banking on the future: biobanking for "omics" approaches to biomarker discovery for Opisthorchis-induced cholangiocarcinoma in Thailand |
Q91650119 | Beta HPV Type 15 Can Interfere With NF-κB Activity and Apoptosis in Human Keratinocytes |
Q55279812 | Beta and gamma human papillomaviruses in anal and genital sites among men: prevalence and determinants. |
Q38365921 | Beta genus papillomaviruses and skin cancer. |
Q43428036 | Beta-papillomavirus DNA loads in hair follicles of immunocompetent people and organ transplant recipients |
Q36344288 | Beyond tobacco in head and neck squamous cell cancers… Emerging era of molecular targeted therapy and virtual biopsy |
Q57061702 | Bile acids drive chemotaxis of Clonorchis sinensis juveniles to the bile duct |
Q91655554 | Bioinformatics analysis of key biomarkers and pathways in KSHV infected endothelial cells |
Q35870615 | Biomarkers of oxidant load and type-specific clearance of prevalent oncogenic human papillomavirus infection: markers of immune response? |
Q89052830 | Biotransformation of benzo[a]pyrene by the thermophilic bacterium Bacillus licheniformis M2-7 |
Q61058238 | Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors |
Q35642804 | Breastfeeding and Helicobacter pylori Infection in Early Childhood: a Continuing Dilemma |
Q35949799 | Burden of Human Papillomavirus among Haitian Immigrants in Miami, Florida: Community-Based Participatory Research in Action |
Q60925276 | Burden of Human papillomavirus (HPV)-related disease and potential impact of HPV vaccines in the Republic of Korea |
Q36629357 | Burden of cervical, anal, and oral HPV in an inner-city pre-vaccine adolescent population |
Q37160564 | C3H/He Mice as an Incompatible Cholangiocarcinoma Model by Clonorchis sinensis, Dicyclanil and N-Nitrosodimethylamine |
Q36720252 | CCR2 and CCR5 genes polymorphisms in women with cervical lesions from Pernambuco, Northeast Region of Brazil: a case-control study |
Q37327810 | CUL2 overexpression driven by CUL2/E2F1/miR-424 regulatory loop promotes HPV16 E7 induced cervical carcinogenesis |
Q36407727 | Can clinical tests help monitor human papillomavirus vaccine impact? |
Q34011249 | Canadian oncogenic human papillomavirus cervical infection prevalence: systematic review and meta-analysis |
Q92138425 | Cancer Incidence among Healthcare Workers in Cancer Centers: A 14-Year Retrospective Cohort Study in Thailand |
Q36859850 | Cancer Mortality Projections in Korea up to 2032. |
Q92306506 | Cancer Tsunami: Emerging Trends, Economic Burden, and Perioperative Implications |
Q38609576 | Cancer in the HIV-Infected Host: Epidemiology and Pathogenesis in the Antiretroviral Era. |
Q51350011 | Cancer mortality in India: a nationally representative survey. |
Q34991464 | Cancer-causing human papillomavirus E6 proteins display major differences in the phospho-regulation of their PDZ interactions. |
Q91945356 | Cancers attributable to infections in Canada |
Q44863515 | Carcinogenic human papillomavirus infection |
Q92995485 | Carcinogenic risk of human papillomavirus (HPV) genotypes and potential effects of HPV vaccines in Korea |
Q34320412 | Carcinogenic viruses and solid cancers without sufficient evidence of causal association. |
Q48009574 | Carcinogenicity of malaria and of some polyomaviruses |
Q34522328 | Case-control study of HLA-G promoter methylation status, HPV infection and cervical neoplasia in Curitiba, Brazil: a pilot analysis |
Q36421345 | Cervical HPV natural history among young Western Cape, South African women: The randomized control EVRI Trial |
Q33888215 | Cervical HPV type-specific pre-vaccination prevalence and age distribution in Croatia |
Q36187634 | Cervical Precancer Risk in HIV-Infected Women Who Test Positive for Oncogenic Human Papillomavirus Despite a Normal Pap Test |
Q42261545 | Cervical cancer cell-derived interleukin-6 impairs CCR7-dependent migration of MMP-9-expressing dendritic cells. |
Q40359221 | Cervical cancer incidence after screening with HPV, cytology, and visual methods: 18-Year follow-up of the Guanacaste cohort. |
Q47380141 | Cervical cancer screening uptake among HIV-positive women in Ontario, Canada: A population-based retrospective cohort study |
Q41644873 | Cervical cancer screening with HPV testing in the Valcamonica (Italy) screening programme. |
Q54901443 | Cervical cancer screening: Epidemiology as the necessary but not sufficient basis of public health practice. |
Q38180277 | Cervical cancer screening: on the way to a shift from cytology to full molecular screening |
Q34441738 | Cervical dysplasia and high-risk human papillomavirus infections among HIV-infected and HIV-uninfected adolescent females in South Africa. |
Q33894231 | Cervical human papillomavirus detection is not affected by menstrual phase |
Q28729883 | Cervical, anal and oral HPV in an adolescent inner-city health clinic providing free vaccinations |
Q30244338 | Changing epidemiology of Helicobacter pylori in Japan |
Q34059657 | Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study |
Q38119854 | Changing trend of Epstein-Barr virus association in Hodgkin lymphoma in the Republic of Korea |
Q44325641 | Characteristics of HPV infection over time in European women who are HIV-1 positive |
Q36735676 | Characterization of Intra-Type Variants of Oncogenic Human Papillomaviruses by Next-Generation Deep Sequencing of the E6/E7 Region |
Q33979909 | Characterization of a novel cutaneous human papillomavirus genotype HPV-125 |
Q54985457 | Characterization of a novel organic solute transporter homologue from Clonorchis sinensis. |
Q90106891 | Characterization of the hepatitis C virus epidemic in Pakistan |
Q37997368 | Characterization of the human papillomavirus (HPV) integration sites into genital cancers |
Q47548612 | Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions |
Q35867432 | Chromosomal copy number alterations and HPV integration in cervical precancer and invasive cancer |
Q33678275 | Chronic inflammation and cytokines in the tumor microenvironment |
Q48134092 | Cigarette Smoking Promotes Infection of Cervical Cells by High-Risk Human Papillomaviruses, but not Subsequent E7 Oncoprotein Expression |
Q92568546 | Cigarette smoking increases the risk of nasopharyngeal carcinoma through the elevated level of IgA antibody against Epstein-Barr virus capsid antigen: A mediation analysis |
Q37006487 | Circulating biomarkers of iron storage and clearance of incident human papillomavirus infection |
Q37223983 | Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline |
Q58749448 | Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework |
Q47599053 | Clinical and analytical performance of the BD Onclarity™ HPV assay for detection of CIN2+ lesions on SurePath samples |
Q35036033 | Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control |
Q37065936 | Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up |
Q30651813 | Clinical impact of the analytical specificity of the hybrid capture 2 test: data from the New Technologies for Cervical Cancer (NTCC) study |
Q37628825 | Clinical validation of AdvanSure GenoBlot assay as primary screening and test of cure for human papillomavirus infection |
Q37757640 | Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology |
Q59800056 | Clinical validation of the Cervista high-risk human papillomavirus test in Chinese women from Fujian province: a cross-sectional study |
Q33969398 | Cloning, expression, and characterization of a novel Opisthorchis viverrini calcium-binding EF-hand protein |
Q33890090 | ClonorESTdb: a comprehensive database for Clonorchis sinensis EST sequences |
Q38571961 | Clonorchiasis |
Q34212501 | Clonorchiasis control: starting from awareness |
Q92605389 | Clonorchis sinensis MF6p/HDM (CsMF6p/HDM) induces pro-inflammatory immune response in RAW 264.7 macrophage cells via NF-κB-dependent MAPK pathways |
Q36204682 | Clonorchis sinensis excretory/secretory products promote the secretion of TNF-alpha in the mouse intrahepatic biliary epithelial cells via Toll-like receptor 4. |
Q40085464 | Clonorchis sinensis infection and co-infection with the hepatitis B virus are important factors associated with cholangiocarcinoma and hepatocellular carcinoma |
Q26315335 | Clonorchis sinensis omega-class glutathione transferases play major roles in the protection of the reproductive system during maturation and the response to oxidative stress |
Q40873145 | Clonorchis sinensis ova in bile juice cytology from a patient with severe hyperbilirubinemia and portal vein thrombosis |
Q34534207 | Clonorchis sinensis, an oriental liver fluke, as a human biological agent of cholangiocarcinoma: a brief review |
Q35093306 | Clustering of multiple human papillomavirus infections in women from a population-based study in Guanacaste, Costa Rica |
Q91709724 | Co-prevalence of human Papillomaviruses (HPV) and Epstein-Barr virus (EBV) in healthy blood donors from diverse nationalities in Qatar |
Q33745553 | Codon Usage Patterns of Tyrosinase Genes in Clonorchis sinensis |
Q37800921 | Commercially available assays for multiplex detection of alpha human papillomaviruses |
Q33798276 | Comparative analysis of HPV16 gene expression profiles in cervical and in oropharyngeal squamous cell carcinoma |
Q38119752 | Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study |
Q54377217 | Comparative evaluation of different DNA extraction methods for HPV genotyping by linear array and INNO-LiPA. |
Q50073530 | Comparative evaluation of the Omniplex-HPV and RFMP HPV PapilloTyper for detecting human papillomavirus genotypes in cervical specimens. |
Q34938697 | Comparing human papillomavirus prevalences in women with normal cytology or invasive cervical cancer to rank genotypes according to their oncogenic potential: a meta-analysis of observational studies |
Q38844434 | Comparison of GeneFinder human papillomavirus (HPV) Liquid Beads Microarray PCR Kit and Hybrid Capture 2 Assay for Detection of HPV Infection. |
Q36256554 | Comparison of HPV prevalence between HPV-vaccinated and non-vaccinated young adult women (20-26 years). |
Q58792602 | Comparison of PI3K Pathway in HPV-Associated Oropharyngeal Cancer With and Without Tobacco Exposure |
Q40264939 | Comparison of anal HPV natural history among men by country of residence: Brazil, Mexico, and the United States. |
Q35342179 | Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study |
Q35066980 | Comparison of clinical performance of Abbott RealTime High Risk HPV test with that of hybrid capture 2 assay in a screening setting. |
Q41284477 | Comparison of clinical performances among Roche Cobas HPV, RFMP HPV PapilloTyper and Hybrid Capture 2 assays for detection of high-risk types of human papillomavirus. |
Q38402711 | Comparison of cobas human papillomavirus test results from primary versus secondary vials of PreservCyt specimens and evaluation of potential cross-contamination |
Q40694854 | Comparison of cytology, HPV DNA testing and HPV 16/18 genotyping alone or combined targeting to the more balanced methodology for cervical cancer screening. |
Q42375482 | Comparison of human papillomavirus (HPV) detection in urine and cervical swab samples using the HPV GenoArray Diagnostic assay |
Q46555447 | Comparison of human papillomavirus testing and cytology for cervical cancer screening in a primary health care setting in the Democratic Republic of the Congo. |
Q34055574 | Comparison of measurements of human papillomavirus persistence for postcolposcopic surveillance for cervical precancerous lesions |
Q92628871 | Comparison of nylon-flocked swab and Dacron swab cytology for anal HSIL detection in transgender women and gay, bisexual, and other men who have sex with men |
Q36118559 | Comparison of the Abbott RealTime High-Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 assays to direct sequencing and genotyping of HPV DNA. |
Q35943033 | Comparison of the GenoFlow human papillomavirus (HPV) test and the Linear Array assay for HPV screening in an Asian population. |
Q40226418 | Comparison of the Natural History of Genital HPV Infection among Men by Country: Brazil, Mexico, and the United States. |
Q33807593 | Comparison of the digene HPV genotyping LQ test and the PANArray HPV genotyping chip for detection of high-risk or probable high-risk human papillomavirus genotypes |
Q41633856 | Comparison of three human papillomavirus DNA assays and one mRNA assay in women with abnormal cytology |
Q33859491 | Comprehensive Human Papillomavirus Genotyping in Cervical Squamous Cell Carcinomas and Its Relevance to Cervical Cancer Prevention in Malawian Women |
Q42246317 | Comprehensive analysis of HPV expression in laryngeal squamous cell carcinoma |
Q37566932 | Concomitant anal and cervical human papillomavirusV infections and intraepithelial neoplasia in HIV-infected and uninfected women |
Q38674506 | Concordance of HPV load and HPV mRNA for 16 carcinogenic/possibly carcinogenic HPV types in paired smear/tissue cervical cancer specimens. |
Q38184467 | Condom use in prevention of Human Papillomavirus infections and cervical neoplasia: systematic review of longitudinal studies |
Q64081988 | Connexin 43 plays an important role in the transformation of cholangiocytes with Clonochis sinensis excretory-secretory protein and N-nitrosodimethylamine |
Q36974955 | Consistent condom use reduces the genital human papillomavirus burden among high-risk men: the HPV infection in men study. |
Q33863292 | Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy |
Q40709573 | Control of HPV-associated cancers with HPV vaccination |
Q40364663 | Control of Opisthorchis viverrini infection for cholangiocarcinoma prevention |
Q57222529 | Control of clonorchiasis in Korea: effectiveness of health education for community leaders and individuals in an endemic area |
Q45189964 | Cost-consequences evaluation between bivalent and quadrivalent HPV vaccines in Italy: the potential impact of different cross-protection profiles. |
Q99637347 | Cost-effectiveness and accuracy of cervical cancer screening with a high-risk HPV genotyping assay vs a nongenotyping assay in China: an observational cohort study |
Q30275666 | Country-specific HPV-related genital disease among men residing in Brazil, Mexico and The United States: The HIM study |
Q44350321 | Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial |
Q36083187 | Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study |
Q29353702 | Cross-sectional study of genital carcinogenic HPV infections in Paramaribo, Suriname: prevalence and determinants in an ethnically diverse population of women in a pre-vaccination era. |
Q36677322 | Cross-sectional study on the prevalence of HPV antibodies in the general population of the Czech Republic |
Q58803075 | Cs1, a Clonorchis sinensis-derived serodiagnostic antigen containing tandem repeats and a signal peptide |
Q34588285 | Culture for genetic manipulation of developmental stages of Schistosoma mansoni |
Q61806398 | Culture of fecal indicator bacteria from snail intestinal tubes as a tool for assessing the risk of Opisthorchis viverrini infection in Bithynia snail habitat |
Q36656216 | Cumulative Impact of HIV and Multiple Concurrent Human Papillomavirus Infections on the Risk of Cervical Dysplasia |
Q57173901 | Current high prevalences of Strongyloides stercoralis and Opisthorchis viverrini infections in rural communities in northeast Thailand and associated risk factors |
Q40056541 | Current status and future prospects for human papillomavirus vaccines |
Q26744209 | Current status and perspectives of Clonorchis sinensis and clonorchiasis: epidemiology, pathogenesis, omics, prevention and control |
Q37030691 | Current understanding of the role of the Brd4 protein in the papillomavirus lifecycle |
Q37018430 | Cutaneous alpha, beta and gamma human papillomaviruses in relation to squamous cell carcinoma of the skin: a population-based study |
Q40612174 | Cutaneous human papillomavirus genotypes in different kinds of skin lesions in Argentina |
Q30409315 | Cutaneous human papillomavirus types detected on the surface of male external genital lesions: a case series within the HPV Infection in Men Study |
Q93026339 | Cyclohexane-1,3-dione as a derivatizing agent for the analysis of aldehydes by micelar electrokinetic chromatography with diode array detection |
Q90164614 | Cytokine Production in Cholangiocarcinoma Cells in Response to Clonorchis sinensis Excretory-Secretory Products and Their Putative Protein Components |
Q49890881 | DNA methylation regulated microRNAs in HPV-16-induced head and neck squamous cell carcinoma (HNSCC). |
Q43857210 | De novo malignant disease after liver transplantation? Risk and surveillance strategies |
Q39068018 | De novo thyroid cancer following solid organ transplantation-A 25-year experience at a high-volume institution with a review of the literature. |
Q30685686 | Deep sequencing of HPV16 genomes: A new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection |
Q28548445 | Degradation of Human PDZ-Proteins by Human Alphapapillomaviruses Represents an Evolutionary Adaptation to a Novel Cellular Niche |
Q40075938 | Degradation of cofilin is regulated by Cbl, AIP4 and Syk resulting in increased migration of LMP2A positive nasopharyngeal carcinoma cells |
Q28475532 | Degradation of p53 by human Alphapapillomavirus E6 proteins shows a stronger correlation with phylogeny than oncogenicity |
Q33935272 | Descriptive epidemiology of cholangiocarcinoma and clonorchiasis in Korea. |
Q92714674 | Detection and genotyping of human papillomavirus virus (HPV): a comparative analysis of clinical performance in cervical and urine samples in Chilean women |
Q35489644 | Detection of Clonorchis sinensis circulating antigen in sera from Chinese patients by immunomagnetic bead ELISA based on IgY. |
Q36970051 | Detection of Human Papillomavirus 16-Specific IgG and IgM Antibodies in Patient Sera: A Potential Indicator of Oral Squamous Cell Carcinoma Risk Factor |
Q93382452 | Detection of human papillomavirus 67 single infection in high-grade cervical lesions: Case report and review of literature |
Q36890494 | Detection of human papillomavirus DNA in peri-tumor tissues and pelvic lymph nodes as potential molecular marker of micrometastasis in cervical cancer |
Q90721452 | Detection of human papillomaviruses in paired healthy skin and actinic keratosis by next generation sequencing |
Q51171929 | Detection of rare and possibly carcinogenic human papillomavirus genotypes as single infections in invasive cervical cancer. |
Q36565494 | Determinants of High-Risk Human Papillomavirus Seroprevalence and DNA Prevalence in Mid-Adult Women |
Q34315668 | Determinants of prevalent human papillomavirus in recently formed heterosexual partnerships: a dyadic-level analysis |
Q36826712 | Development and characterization of the cobas human papillomavirus test |
Q47149093 | Development and implementation of a system for the early identification of emerging risks in food and feed |
Q35834831 | Development of a fluorescence-based multiplex genotyping method for simultaneous determination of human papillomavirus infections and viral loads |
Q37726438 | Development of a polymerase chain reaction applicable to rapid and sensitive detection of Clonorchis sinensis eggs in human stool samples |
Q28478834 | Developmental transcriptomic features of the carcinogenic liver fluke, Clonorchis sinensis |
Q90594835 | Diagnostic Utility of HPV16 E6 mRNA or E7 mRNA Quantitative Expression for Cervical Cells of Patients with Dysplasia and Carcinoma |
Q42206121 | Diagnostic accuracy of colposcopy in relation to human papillomavirus genotypes and multiple infection |
Q38842960 | Dicrocoelium dendriticum induces autophagic vacuoles accumulation in human hepatocarcinoma cells. |
Q28383010 | Diet and the risk of head and neck cancer: a pooled analysis in the INHANCE consortium |
Q36474916 | Dietary glycemic load, glycemic index, and carbohydrates on the risk of primary liver cancer among Chinese women and men. |
Q47266595 | Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma. |
Q37363392 | Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial Assays |
Q36205419 | Differential Protein Expression in the Hemolymph of Bithynia siamensis goniomphalos Infected with Opisthorchis viverrini. |
Q34734252 | Differential activation of diverse glutathione transferases of Clonorchis sinensis in response to the host bile and oxidative stressors |
Q33846801 | Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy. |
Q44399871 | Digestive cancer management in Asia: position statements: a report on GI Oncology Summit in 2011. |
Q34105234 | Disability weight of Clonorchis sinensis infection: captured from community study and model simulation |
Q37496183 | Disagreement between human papillomavirus assays: an unexpected challenge for the choice of an assay in primary cervical screening |
Q29353543 | Distinctive distribution of HPV genotypes in cervical cancers in multi-ethnic Suriname: implications for prevention and vaccination |
Q40129728 | Distribution and attribution of high-risk human papillomavirus genotypes in cervical precancerous lesions in China |
Q35685061 | Distribution of HPV genotypes in cervical intraepithelial lesions and cervical cancer in Tanzanian women |
Q38984023 | Distribution of Vaccine-Type Human Papillomavirus Does Not Differ by Race or Ethnicity Among Unvaccinated Young Women |
Q46208405 | Distribution of human papillomavirus 58 and 52 E6/E7 variants in cervical neoplasia in Chinese women |
Q39745725 | Distribution of human papillomavirus genotypes in Paraguayan women according to the severity of the cervical lesion |
Q57089348 | Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada |
Q42260259 | Distribution of human papillomavirus genotypes, assessment of HPV 16 and 18 viral load and anal related lesions in HIV positive patients: a cross-sectional analysis |
Q36769394 | Distribution of human papillomaviruses and bacterial vaginosis in HIV positive women with abnormal cytology in Mombasa, Kenya |
Q40681570 | Diversity of beta-papillomavirus at anogenital and oral anatomic sites of men: The HIM Study. |
Q38963668 | Does persistent HIV replication explain continued lymphoma incidence in the era of effective antiretroviral therapy? |
Q91632927 | Downregulation of RAGE Inhibits Cell Proliferation and Induces Apoptosis via Regulation of PI3K/AKT Pathway in Cervical Squamous Cell Carcinoma |
Q57089344 | Dry self-sampling versus provider-sampling of cervicovaginal specimens for human papillomavirus detection in the Inuit population of Nunavik, Quebec |
Q41929232 | Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial |
Q57044322 | Dynamics and Determinants of HPV Infection: The Michigan HPV and Oropharyngeal Cancer (M-HOC) Study |
Q37718767 | Dynamics of high-risk nonvaccine human papillomavirus types after actual vaccination scheme |
Q45391153 | E6 and E7 variants of human papillomavirus-16 and -52 in Japan, the Philippines, and Vietnam |
Q39378537 | Early detection and estimation of infection burden by real-time PCR in rats experimentally infected with Clonorchis sinensis. |
Q28472903 | Effect of control strategies on prevalence, incidence and re-infection of clonorchiasis in endemic areas of China |
Q35871517 | Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer |
Q33647741 | Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study |
Q90711625 | Effect of weighting for sampling and non-response on estimates of STI prevalence in the third British National Survey of Sexual Attitudes and Lifestyles (Natsal-3) |
Q50065432 | Effective use of human papillomavirus testing for cervical cancer screening requires extended intervals to target persistent infections and precancerous lesions. |
Q41051528 | Effectiveness of human papillomavirus vaccine against incident and persistent infections among young girls: Results from a longitudinal Dutch cohort study |
Q43267321 | Efficacy of artesunate and artemether against Clonorchis sinensis in rabbits |
Q94539195 | Efficient production of HPV16 E2 protein from HPV16 late mRNAs spliced from SD880 to SA2709 |
Q40877197 | Egg-specific expression of protein with DNA methyltransferase activity in the biocarcinogenic liver fluke Clonorchis sinensis |
Q37642847 | Elevated prevalence of Helicobacter species and virulence factors in opisthorchiasis and associated hepatobiliary disease |
Q56904286 | Emerging and re-emerging infectious disease in otorhinolaryngology |
Q38319580 | Environmental (nongenetic) factors in gynecological cancers: update and future perspectives |
Q37078556 | Epidemiologic approaches to evaluating the potential for human papillomavirus type replacement postvaccination |
Q34182283 | Epidemiologic characterization of human papillomavirus infection in rural Chaozhou, eastern Guangdong Province of China |
Q49265752 | Epidemiological study of high-risk human papillomavirus infection in subjects with abnormal cytological findings in cervical cancer screening. |
Q57922398 | Epidemiology and biology of cutaneous human papillomavirus |
Q37727399 | Epidemiology of cervical cancer in Colombia |
Q42690821 | Epidemiology of cervical human papillomavirus (HPV) infection and squamous intraepithelial lesions (SIL) among a cohort of HIV-infected and uninfected Ghanaian women |
Q37669732 | Epidemiology of oral human papillomavirus infection |
Q35841460 | Epidemiology of, and behavioural risk factors for, sexually transmitted human papillomavirus infection in men and women in Britain. |
Q55346681 | Epidermodysplasia Verruciformis: Inborn Errors of Immunity to Human Beta-Papillomaviruses. |
Q37314766 | Epitomics: IgG-epitome decoding of E6, E7 and L1 proteins from oncogenic human papillomavirus type 58. |
Q90481228 | Epstein Barr Virus Associated Lymphomas and Epithelia Cancers in Humans |
Q90483607 | Epstein-Barr virus and human papillomaviruses as favorable prognostic factors in nasopharyngeal carcinoma: A nationwide study in Finland |
Q35125635 | Epstein-Barr virus microRNAs and lung cancer. |
Q40108143 | Epstein-Barr virus positivity is associated with angiogenesis in, and poorer survival of, patients receiving standard treatment for classical Hodgkin's lymphoma. |
Q55312268 | Epstein–Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update. |
Q28076178 | Esophageal Cancer in Golestan Province, Iran: A Review of Genetic Susceptibility and Environmental Risk Factors |
Q90630982 | Estimating incidence rates of grouped HPV types: A systematic review and comparison of the impact of different epidemiological assumptions |
Q26781786 | Estimation of Cancer Burden Attributable to Infection in Asia |
Q34493286 | Estimation of HPV prevalence in young women in Scotland; monitoring of future vaccine impact |
Q37888518 | Estimation of cancer cases and deaths attributable to infection in China |
Q41056813 | Ethnic and geographic variations in HPV prevalence and genotype distribution in north-western Yunnan, China |
Q55097392 | European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination. |
Q39620969 | Evaluation of carcinogenic hazard of diesel engine exhaust needs to consider revolutionary changes in diesel technology |
Q31083741 | Evaluation of human leukocyte antigen-A (HLA-A), other non-HLA markers on chromosome 6p21 and risk of nasopharyngeal carcinoma |
Q35282198 | Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination |
Q37004759 | Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer |
Q36511847 | Evaluation of the management of Hr-HPV+/PapTest- women: results at 1-year recall |
Q47714066 | Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies |
Q36949283 | Evolution of human papillomavirus carcinogenicity |
Q38114642 | Evolution of the papillomaviridae |
Q45765408 | Exploring individual HPV coinfections is essential to predict HPV-vaccination impact on genotype distribution: a model-based approach |
Q55234256 | Exposure to Antineoplastic Agents Induces Cytotoxicity in Nurse Lymphocytes: Role of Mitochondrial Damage and Oxidative Stress. |
Q28266917 | Exposure to Bovine Leukemia Virus Is Associated with Breast Cancer: A Case-Control Study |
Q48785791 | Expression of programmed cell death 1 and programmed cell death ligand 1 in extranodal NK/T-cell lymphoma, nasal type. |
Q46604994 | Extended Middle East and North Africa: cervical cancer and human papillomavirus: can we make the case for prevention in this "relatively" low prevalence region? |
Q38949757 | Extracellular calcium regulates keratinocyte proliferation and HPV 16 E6 RNA expression in vitro. |
Q38684508 | Extrahepatic manifestations of HCV: the role of direct acting antivirals |
Q35053172 | Factors affecting the prevalence of strongly and weakly carcinogenic and lower-risk human papillomaviruses in anal specimens in a cohort of men who have sex with men (MSM). |
Q57034643 | Factors associated with high-risk human papillomavirus test utilization and infection: a population-based study of uninsured and underinsured women |
Q86657082 | Factors associated with human papillomavirus infection among women in the Northwest Territories |
Q37620568 | Fallen angels or risen apes? A tale of the intricate complexities of imbalanced immune responses in the pathogenesis and progression of immune-mediated and viral cancers |
Q64089921 | False positive cervical HPV screening test results |
Q36541982 | Familial gastric cancer: detection of a hereditary cause helps to understand its etiology |
Q34433015 | Feasibility study of a human papillomavirus E6 oncoprotein test for diagnosis of cervical precancer and cancer |
Q28287720 | Food-borne trematodiases in Southeast Asia epidemiology, pathology, clinical manifestation and control |
Q56762499 | Frequency and coinfection between genotypes of human papillomavirus in a population of asymptomatic women in northern Peru |
Q36055770 | Frequency and risk factors for prevalent, incident, and persistent genital carcinogenic human papillomavirus infection in sexually active women: community based cohort study |
Q36255382 | Full-length single-cell RNA-seq applied to a viral human cancer: applications to HPV expression and splicing analysis in HeLa S3 cells |
Q28078631 | Functional Roles of E6 and E7 Oncoproteins in HPV-Induced Malignancies at Diverse Anatomical Sites |
Q34363927 | Functional analysis of Kaposi's sarcoma-associated herpesvirus vFLIP expression reveals a new mode of IRES-mediated translation |
Q37403181 | Functional genes and proteins of Clonorchis sinensis |
Q43745960 | Functional polymorphism rs4072037 in MUC1 gene contributes to the susceptibility to gastric cancer: evidence from pooled 6,580 cases and 10,324 controls |
Q36180589 | Functional variants of human papillomavirus type 16 demonstrate host genome integration and transcriptional alterations corresponding to their unique cancer epidemiology. |
Q59357086 | Gammaherpesvirus infection and malignant disease in rhesus macaques experimentally infected with SIV or SHIV |
Q33600457 | Gastric Cancer in the Era of Precision Medicine |
Q35480890 | Gastric cancer epidemiology in Korea |
Q34194651 | Gastric cancer: an infectious disease |
Q59361031 | Generation of a novel next-generation sequencing-based method for the isolation of new human papillomavirus types |
Q35530646 | Generic microtiter plate assay for triaging clinical specimens prior to genotyping of human papillomavirus DNA via consensus PCR. |
Q38376969 | Genetic and Environmental Factors in Invasive Cervical Cancer: Design and Methods of a Classical Twin Study |
Q34056375 | Genetic manipulation of Schistosoma haematobium, the neglected schistosome. |
Q30279220 | Genital Human Papillomavirus Infection Progression to External Genital Lesions: The HIM Study. |
Q36376205 | Genital human papillomavirus (HPV) concordance in heterosexual couples. |
Q35463790 | Genital transmission of human papillomavirus in recently formed heterosexual couples |
Q37461632 | Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer |
Q35680789 | Genome-wide characterization of microsatellites and marker development in the carcinogenic liver fluke Clonorchis sinensis |
Q36432579 | Genomic polymorphism of human papillomavirus type 52 in women from Northeast China |
Q43849421 | Genotoxicity induced by Taenia solium and its reduction by immunization with calreticulin in a hamster model of taeniosis. |
Q39775493 | Genotypes distribution of human papillomavirus in cervical samples of Ecuadorian women |
Q35141881 | Genotypic distribution of human papillomavirus (HPV) and cervical cytology findings in 5906 Thai women undergoing cervical cancer screening programs |
Q39393413 | Genotypic prevalence of human papillomavirus infection during normal pregnancy: a cross-sectional study |
Q40892448 | German-Austrian guidelines on anal dysplasia and anal cancer in HIV-positive individuals: prevention, diagnosis, and treatment |
Q37069804 | Global Genomic Diversity of Human Papillomavirus 11 Based on 433 Isolates and 78 Complete Genome Sequences |
Q29620303 | Global burden of cancers attributable to infections in 2008: a review and synthetic analysis |
Q34620280 | Global burden of deaths from Epstein-Barr virus attributable malignancies 1990-2010 |
Q39484712 | Global burden of food-borne trematodiasis |
Q37959784 | Global burden of human food-borne trematodiasis: a systematic review and meta-analysis |
Q38064060 | Global burden of human papillomavirus and related diseases. |
Q22241238 | Global cancer statistics |
Q33744003 | Global genomic diversity of human papillomavirus 6 based on 724 isolates and 190 complete genome sequences |
Q35971370 | Grand challenges in cancer epidemiology and prevention |
Q37082877 | Gut bacteria and cancer |
Q35592111 | Gut bacteria require neutrophils to promote mammary tumorigenesis |
Q35987613 | H. pylori vaccines: why we still don't have any |
Q44317446 | HAART and progression to high-grade anal intraepithelial neoplasia in men who have sex with men and are infected with HIV. |
Q36675916 | HIV Infection Alters the Spectrum of HPV Subtypes Found in Cervical Smears and Carcinomas from Kenyan Women |
Q37214352 | HIV and HPV infections and ocular surface squamous neoplasia: systematic review and meta-analysis. |
Q35031952 | HIV associated high-risk HPV infection among Nigerian women. |
Q90646260 | HIV modifies the effect of tobacco smoking on oral human papillomavirus infection |
Q38149333 | HPV E6 oncoprotein as a potential therapeutic target in HPV related cancers |
Q89666353 | HPV E6/E7 mRNA test for the detection of high grade cervical intraepithelial neoplasia (CIN2+): a systematic review |
Q36240830 | HPV Genotypes distribution in Indian women with and without cervical carcinoma: Implication for HPV vaccination program in Odisha, Eastern India |
Q35908027 | HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients |
Q89834860 | HPV Oncoproteins and the Ubiquitin Proteasome System: A Signature of Malignancy? |
Q58994032 | HPV Prevalence and Detection of Rare HPV Genotypes in Hong Kong Women from Southern China with Cytological Abnormalities |
Q40211544 | HPV SEROSTATUS PRE- AND POST-VACCINATION IN A RANDOMIZED PHASE II PREPAREDNESS TRIAL AMONG YOUNG WESTERN CAPE, SOUTH AFRICAN WOMEN: THE EVRI TRIAL. |
Q41045517 | HPV and EBV Infections in Neck Metastases from Occult Primary Squamous Cell Carcinoma: Another Virus-Related Neoplastic Disease in the Head and Neck Region |
Q37144878 | HPV and oral lesions: preventive possibilities, vaccines and early diagnosis of malignant lesions |
Q34157209 | HPV catch-up vaccination of young women: a systematic review and meta-analysis |
Q36888568 | HPV genotype distribution according to severity of cervical neoplasia using the Digene HPV genotyping LQ test. |
Q57193588 | HPV genotype distribution among women with normal and abnormal cervical cytology presenting in a tertiary gynecology referral Clinic in Ethiopia |
Q31121182 | HPV genotype distribution in Brazilian women with and without cervical lesions: correlation to cytological data |
Q34313933 | HPV genotype distribution in cervical intraepithelial neoplasia among HIV-infected women in Pune, India |
Q50044506 | HPV genotype profile in a Norwegian cohort with ASC-US and LSIL cytology with three year cumulative risk of high grade cervical neoplasia. |
Q34485433 | HPV genotypes and associated cervical cytological abnormalities in women from the Pearl River Delta region of Guangdong province, China: a cross-sectional study |
Q40643444 | HPV genotypes detected in the oropharyngeal mucosa of HIV-infected men who have sex with men in Northern Italy. |
Q49907625 | HPV genotyping for the cross-sectional and longitudinal probability of developing CIN2. |
Q46699275 | HPV in urology. Basic principles and controversies |
Q36746765 | HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker? |
Q34983800 | HPV prevalence among women from Appalachia: results from the CARE project |
Q61447073 | HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong's largest independent pathology laboratory |
Q34006684 | HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 human papillomavirus genotype microarray system |
Q42203937 | HPV prevalence and type distribution in women with normal or abnormal Pap smear in Bulgaria |
Q34618650 | HPV testing by cobas HPV test in a population from Catalonia |
Q64054260 | HPV testing for cervical cancer screening: technical improvement of laboratory logistics and good clinical performance of the cobas 6800 in comparison to the 4800 system |
Q36480261 | HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies. |
Q57494504 | HPV vaccination is fundamental for reducing or erradicate penile cancer | Opinion: NO |
Q35441106 | HPV-16 impairs the subcellular distribution and levels of expression of protein phosphatase 1γ in cervical malignancy |
Q40396965 | HPV-6 Molecular Variants Association With the Development of Genital Warts in Men: The HIM Study |
Q36856284 | HPV-based Tests for Cervical Cancer Screening and Management of Cervical Disease |
Q35598917 | HPV-induced anal lesions |
Q30580161 | HPV-related cancers after solid organ transplantation in the United States |
Q30252655 | HPV-related external genital lesions among men residing in Brazil |
Q36901882 | HPV16 CpG methyl-haplotypes are associated with cervix precancer and cancer in the Guanacaste natural history study |
Q40693093 | HPV16 Sublineage Associations With Histology-Specific Cancer Risk Using HPV Whole-Genome Sequences in 3200 Women |
Q54242431 | HTLV-1 Alters T Cells for Viral Persistence and Transmission. |
Q56984609 | Harnessing Genomic Technologies to Explore the Molecular Biology of Liver Flukes-Major Implications for Fundamental and Applied Research |
Q35858737 | Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa |
Q34612386 | HelicoVax: epitope-based therapeutic Helicobacter pylori vaccination in a mouse model |
Q35172224 | Helicobacter pylori Infection and Gastric Adenocarcinoma. |
Q37350096 | Helminth infection in southern Laos: high prevalence and low awareness |
Q34128439 | Helminths in human carcinogenesis |
Q40110872 | Hepatic iron overload is associated with hepatocyte apoptosis during Clonorchis sinensis infection |
Q45323588 | Hepatitis B virus X protein inhibits apoptosis by modulating endoplasmic reticulum stress response |
Q45367473 | Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan |
Q34106504 | Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study. |
Q38607430 | Hepatitis C Virus Genotypes in the Middle East and North Africa: Distribution, Diversity, and Patterns |
Q34101320 | Hepatitis C virus prevalence and clearance among US blood donors, 2006-2007: associations with birth cohort, multiple pregnancies, and body mass index |
Q26750997 | Hepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know? |
Q38163597 | Hepatocellular carcinoma and cholangiocarcinoma: an update |
Q26750646 | Hepatocellular carcinoma and the risk of occupational exposure |
Q35756750 | Heterogeneity of (18)F-FDG PET combined with expression of EGFR may improve the prognostic stratification of advanced oropharyngeal carcinoma |
Q35860988 | Heterogeneous Nuclear Ribonucleoprotein C Proteins Interact with the Human Papillomavirus Type 16 (HPV16) Early 3'-Untranslated Region and Alleviate Suppression of HPV16 Late L1 mRNA Splicing |
Q34268415 | Hierarchical clustering of human papilloma virus genotype patterns in the ASCUS-LSIL triage study |
Q30206108 | High HIV, HPV, and STI prevalence among young Western Cape, South African women: EVRI HIV prevention preparedness trial |
Q43469953 | High HPV infection prevalence in men from infertile couples and lack of relationship between seminal HPV infection and sperm quality. |
Q58604536 | High Prevalence of Human Papillomavirus Types 56 and 70 Identified in the Native Populations of Sabah, Malaysia |
Q30383606 | High Toxoplasma gondii Seropositivity among Brain Tumor Patients in Korea. |
Q40117867 | High diversity of alpha, beta and gamma human papillomaviruses in genital samples from HIV-negative and HIV-positive heterosexual South African men. |
Q36607257 | High frequency of human papillomavirus detection in the vagina before first vaginal intercourse among females enrolled in a longitudinal cohort study |
Q34694485 | High genital prevalence of cutaneous human papillomavirus DNA on male genital skin: the HPV Infection in Men Study |
Q47559002 | High human papillomavirus (HPV) prevalence in South African adolescents and young women encourages expanded HPV vaccination campaigns |
Q37030821 | High prevalence and incidence of human papillomavirus in a cohort of healthy young African female subjects |
Q97549213 | High prevalence of Clonorchis sinensis infections and coinfection with hepatitis virus in riverside villages in northeast China |
Q64359199 | High prevalence of cervical high-risk human papillomavirus infection mostly covered by Gardasil-9 prophylactic vaccine in adult women living in N'Djamena, Chad |
Q46576040 | High prevalence of human papillomavirus infection in Eastern European and West African women immigrants in South Italy |
Q93099597 | High prevalence of human papillomavirus infection in HIV-infected women living in French Antilles and French Guiana |
Q35418185 | High risk human papillomavirus persistence among HIV-infected young women in South Africa |
Q97645835 | High-Risk HPV Oncoproteins and PD-1/PD-L1 Interplay in Human Cervical Cancer: Recent Evidence and Future Directions |
Q35619059 | High-Risk Human Papillomavirus (HPV) Infection and Cervical Cancer Prevention in Britain: Evidence of Differential Uptake of Interventions from a Probability Survey |
Q64241375 | High-resolution anoscopy in HIV-infected men: Assessment of the learning curve and factors that improve the performance |
Q36559876 | High-risk human papillomavirus E6 oncoproteins interact with 14-3-3ζ in a PDZ binding motif-dependent manner |
Q91592321 | High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology |
Q37187658 | Higher prevalence and gene amplification of HPV16 in oropharynx as compared to oral cavity |
Q51773647 | Highlights of the 26th international papillomavirus conference and workshops. |
Q34160028 | Histopathological diagnosis of opisthorchiasis in an immigrant |
Q56959696 | Hookworm exposure decreases human papillomavirus uptake and cervical cancer cell migration through systemic regulation of epithelial-mesenchymal transition marker expression |
Q55112573 | Host chemokine signature as a biomarker for the detection of pre-cancerous cervical lesions. |
Q28069401 | Host-Microbiome Interaction and Cancer: Potential Application in Precision Medicine |
Q99711630 | How Can Gene-Expression Information Improve Prognostic Prediction in TCGA Cancers: An Empirical Comparison Study on Regularization and Mixed Cox Models |
Q51587656 | How do snails meet fish? Landscape perspective needed to study parasite prevalence. |
Q92128486 | Human DNA Virus Exploitation of the MAPK-ERK Cascade |
Q40056132 | Human Immunodeficiency Virus Status Differentially Associated With Genital and Anal Human Papillomavirus Infection Among Chinese Men Who Have Sex With Men: A Cross-Sectional Survey |
Q55239038 | Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers. |
Q45357821 | Human Papilloma Virus infection in sexually active adolescent girls |
Q36466049 | Human Papillomavirus (HPV) Genotyping: Automation and Application in Routine Laboratory Testing |
Q47664629 | Human Papillomavirus 16 (HPV-16), HPV-18, and HPV-31 E6 Override the Normal Phosphoregulation of E6AP Enzymatic Activity |
Q33740118 | Human Papillomavirus 16, 18, 31 and 45 viral load, integration and methylation status stratified by cervical disease stage. |
Q35898888 | Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above |
Q90454830 | Human Papillomavirus Awareness, Vaccine Status, and Risk Factors in Female Emergency Patients |
Q89620954 | Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy |
Q37594497 | Human Papillomavirus Infection and Cervical Neoplasia among Migrant Women Living in Italy |
Q36675236 | Human Papillomavirus Laboratory Testing: the Changing Paradigm |
Q53548285 | Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient. |
Q64254644 | Human Papillomavirus infection in senegalese female sex workers |
Q35729429 | Human U6 promoter drives stronger shRNA activity than its schistosome orthologue in Schistosoma mansoni and human fibrosarcoma cells |
Q36262929 | Human leukocyte antigen class II DRB1*1302 allele protects against cervical cancer: At which step of multistage carcinogenesis? |
Q39049854 | Human liver flukes |
Q64090225 | Human liver flukes in China and ASEAN: Time to fight together |
Q61448596 | Human papilloma virus and breast cancer: the role of inflammation and viral expressed proteins |
Q47555534 | Human papilloma virus: An etiological and prognostic factor for oral cancer? |
Q34487394 | Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with Amplicor HPV and Hybrid Capture 2 assays for detection of high-grade lesions of the uterine cervix |
Q35867881 | Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with cobas 4800 HPV and Hybrid Capture 2 tests for detection of high-grade lesions of the uterine cervix |
Q44413201 | Human papillomavirus (HPV) E6/E7 mRNA as a triage test after detection of HPV 16 and HPV 18 DNA. |
Q37826532 | Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix |
Q35051454 | Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California |
Q33774640 | Human papillomavirus (HPV) in young women in Britain: Population-based evidence of the effectiveness of the bivalent immunisation programme and burden of quadrivalent and 9-valent vaccine types |
Q47599124 | Human papillomavirus (HPV) perinatal transmission and risk of HPV persistence among children: Design, methods and preliminary results of the HERITAGE study |
Q37700184 | Human papillomavirus 33 worldwide genetic variation and associated risk of cervical cancer |
Q28659720 | Human papillomavirus 45 genetic variation and cervical cancer risk worldwide |
Q37481203 | Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma. |
Q35677956 | Human papillomavirus DNA in men who have sex with men: type-specific prevalence, risk factors and implications for vaccination strategies. |
Q42217974 | Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy |
Q90001554 | Human papillomavirus E7 oncoprotein targets RNF168 to hijack the host DNA damage response |
Q27023127 | Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts |
Q38064067 | Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis |
Q28069930 | Human papillomavirus and gastrointestinal cancer: A review |
Q35144254 | Human papillomavirus antibodies and future risk of anogenital cancer: a nested case-control study in the European prospective investigation into cancer and nutrition study |
Q55287837 | Human papillomavirus clustering patterns among HIV-infected and HIV-uninfected adolescent females in South Africa. |
Q27026226 | Human papillomavirus genome variants |
Q49476041 | Human papillomavirus genotype affects metastatic rate following radiotherapy in patients with uterine cervical cancer. |
Q36509823 | Human papillomavirus genotype attribution and estimation of preventable fraction of anal intraepithelial neoplasia cases among HIV-infected men who have sex with men |
Q45206974 | Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study |
Q51426652 | Human papillomavirus genotype detection and viral load in paired genital and urine samples from both females and males. |
Q47621642 | Human papillomavirus genotype distribution among HPV-positive women in Sichuan province, Southwest China |
Q47548474 | Human papillomavirus genotype distribution in cervical cancer biopsies from Nepalese women |
Q36358126 | Human papillomavirus genotypes among women with or without HIV infection: an epidemiological study of Moroccan women from the Souss area |
Q34536611 | Human papillomavirus genotypes detected in clinician-collected and self-collected specimens from women living in the Mississippi Delta |
Q34863458 | Human papillomavirus genotypes distribution in 175 invasive cervical cancer cases from Brazil |
Q44252736 | Human papillomavirus genotypes distribution in cervical samples from Uruguayan women |
Q33984185 | Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3 |
Q92039393 | Human papillomavirus genotypes in women with invasive cervical cancer with and without human immunodeficiency virus infection in Botswana |
Q36131433 | Human papillomavirus genotyping by Linear Array and Next-Generation Sequencing in cervical samples from Western Mexico |
Q47128102 | Human papillomavirus in semen and the risk for male infertility: a systematic review and meta-analysis |
Q34903696 | Human papillomavirus in the lesions of the oral mucosa according to topography. |
Q42244723 | Human papillomavirus infection among human immunodeficiency virus-infected women in Maharashtra, India |
Q40107289 | Human papillomavirus infection among male clients of female sex workers soliciting sex in brothels in Peru |
Q33630795 | Human papillomavirus infection and squamous cell carcinoma of the conjunctiva |
Q41747762 | Human papillomavirus infection in Bowen disease: negative p53 expression, not p16(INK4a) overexpression, is correlated with human papillomavirus-associated Bowen disease |
Q42270400 | Human papillomavirus infection in women in four regions of Senegal |
Q34471165 | Human papillomavirus infection in women with and without cervical cancer in Ibadan, Nigeria |
Q42206744 | Human papillomavirus infection requires the TSG101 component of the ESCRT machinery |
Q41465634 | Human papillomavirus infections in Mexican women with normal cytology, precancerous lesions, and cervical cancer: type-specific prevalence and HPV coinfections |
Q37257349 | Human papillomavirus molecular biology and disease association |
Q42277972 | Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa |
Q35821601 | Human papillomavirus prevalence in South African women and men according to age and human immunodeficiency virus status |
Q41651390 | Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening. |
Q37909359 | Human papillomavirus testing and genotyping in cervical screening |
Q34997580 | Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic review |
Q34616083 | Human papillomavirus testing in the prevention of cervical cancer |
Q39477130 | Human papillomavirus testing versus cytology in primary cervical cancer screening: End-of-study and extended follow-up results from the Canadian cervical cancer screening trial |
Q58794974 | Human papillomavirus type 16 antagonizes IRF6 regulation of IL-1β |
Q34116193 | Human papillomavirus type 16 long control region and E6 variants stratified by cervical disease stage |
Q40892020 | Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia |
Q42262648 | Human papillomavirus type-specific persistence and recurrence after treatment for cervical dysplasia |
Q37309275 | Human papillomavirus types distribution in organised cervical cancer screening in France |
Q58452367 | Human papillomavirus vaccination for men: advancing policy and practice |
Q35558593 | Human papillomavirus vaccination: current indications and future directions |
Q38218612 | Human papillomavirus vaccination: where are we now? |
Q37762242 | Human papillomavirus vaccines: current status and future prospects |
Q36417526 | Human papillomavirus variants among Inuit women in northern Quebec, Canada |
Q37631295 | Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment. |
Q37901056 | Human papillomavirus: science and technologies for the elimination of cervical cancer |
Q36545311 | Human papillomavirus: what every provider should know. |
Q93025985 | Human papillomaviruses 16 and 58 are distributed widely among women living in Shanghai, China, with high-grade, squamous intraepithelial lesions |
Q38026999 | Human papillomaviruses and the specificity of PDZ domain targeting. |
Q46344926 | Human tumour viruses and the deregulation of cell polarity in cancer |
Q37711147 | Human viral oncogenesis: a cancer hallmarks analysis |
Q54266087 | Human γ-Herpesvirus Infection, Tumorigenesis, and Immune Control in Mice with Reconstituted Human Immune System Components. |
Q39909954 | Hybrid Capture 2 and cobas human papillomavirus assays perform similarly on SurePath samples from women with abnormalities. |
Q51546154 | Identification and biochemical characterization of two novel peroxiredoxins in a liver fluke, Clonorchis sinensis. |
Q34052874 | Identification and characterization of a novel 21.6-kDa tegumental protein from Clonorchis sinensis |
Q47427658 | Identification and characterization of myophilin-like protein: a life stage and tissue-specific antigen of Clonorchis sinensis |
Q44063748 | Identification and characterization of the second cysteine protease inhibitor of Clonorchis sinensis (CsStefin-2). |
Q35262229 | Identification and molecular characterization of Parkin in Clonorchis sinensis |
Q33908196 | Identification of G protein-coupled receptors in Schistosoma haematobium and S. mansoni by comparative genomics |
Q31048577 | Identification of Known and Novel Recurrent Viral Sequences in Data from Multiple Patients and Multiple Cancers |
Q41713745 | Identification of a lysosomal pathway regulating degradation of the bone morphogenetic protein receptor type II. |
Q49438443 | Identification of key miRNAs and genes associated with stomach adenocarcinoma from The Cancer Genome Atlas database. |
Q40117225 | Identifying Helminth Infections via Routine Fecal Parasitological Examinations in Korea |
Q37416397 | Identifying molecular drivers of gastric cancer through next-generation sequencing |
Q38853095 | Immediate Antiretroviral Therapy Reduces Risk of Infection-Related Cancer During Early HIV Infection |
Q97436156 | Immediate histologic correlation in women with atypical squamous cells of undetermined significance cytology and positive high-risk HPV: A retrospective review of 6000 cases in a large academic women's hospital |
Q92151588 | Immune Control and Vaccination against the Epstein-Barr Virus in Humanized Mice |
Q37092377 | Immunization and challenge shown by hamsters infected with Opisthorchis viverrini following exposure to gamma-irradiated metacercariae of this carcinogenic liver fluke. |
Q64280722 | Immunodeficiencies that predispose to pathologies by human oncogenic γ-herpesviruses |
Q41136544 | Immunohistochemical expression of IMP3 and p53 in inflammatory lesions and neoplastic lesions of the gastric mucosa |
Q35818624 | Immunologic Control of Mus musculus Papillomavirus Type 1. |
Q40045752 | Immunopathogenesis of HPV-Associated Cancers and Prospects for Immunotherapy |
Q35044376 | Immunoprevention of human papillomavirus-associated malignancies |
Q37371401 | Impact of HPV infection on the development of head and neck cancer |
Q40571982 | Impact of Serum Antibodies to HPV Serotypes 6, 11, 16, and 18 to Risks of Subsequent Genital HPV Infections in Men: The HIM Study. |
Q42209167 | Impact of human papillomavirus coinfections on the risk of high-grade squamous intraepithelial lesion and cervical cancer |
Q33883581 | Impact of improved classification on the association of human papillomavirus with cervical precancer |
Q45358139 | Impact of the Epstein-Barr virus positivity on Hodgkin's lymphoma in a large cohort from a single institute in Korea |
Q92030460 | Importance of the immune system in head and neck cancer |
Q91735602 | Improving diagnostic performance of the Kato-Katz method for Clonorchis sinensis infection through multiple samples |
Q36445316 | In vitro maintenance of Clonorchis sinensis adult worms |
Q21558774 | Inactivation of p53 rescues the maintenance of high risk HPV DNA genomes deficient in expression of E6 |
Q37524405 | Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study. |
Q38215252 | Incidence and clinical management of oral human papillomavirus infection in men: a series of key short messages |
Q36201512 | Incidence and persistence of carcinogenic genital human papillomavirus infections in young women with or without Chlamydia trachomatis co-infection |
Q40138686 | Incidence and risk factors for human papillomavirus infections in young female online daters. |
Q64111789 | Incidence and time trends of anal cancer among people living with HIV in Australia |
Q39229572 | Incidence of Endemic Burkitt Lymphoma in Three Regions of Mozambique |
Q36915102 | Incidence, Duration, Persistence, and Factors Associated With High-risk Anal Human Papillomavirus Persistence Among HIV-negative Men Who Have Sex With Men: A Multinational Study |
Q40743154 | Incident Detection of High-Risk Human Papillomavirus Infections in a Cohort of High-Risk Women Aged 25-65 Years |
Q35037011 | Incident anal human papillomavirus and human papillomavirus-related sequelae in HIV-infected versus HIV-uninfected adolescents in the United States |
Q33936349 | Increased all-cause and cancer mortality in HTLV-II infection. |
Q89590945 | Increasing Cervical Cancer Incidence in Rural Eastern Cape Province of South Africa From 1998 to 2012: A Population-Based Cancer Registry Study |
Q33574454 | Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions |
Q38956930 | Induction of cancer-related microRNA expression profiling using excretory-secretory products of Clonorchis sinensis |
Q26863592 | Infection and cancer in multicellular organisms |
Q48043820 | Infection with high-risk HPV types among female sex workers in northern Vietnam |
Q27692556 | Infection with the carcinogenic human liver fluke, Opisthorchis viverrini |
Q34909875 | Infection with the carcinogenic liver fluke Opisthorchis viverrini modifies intestinal and biliary microbiome. |
Q38906518 | Infection-related and -unrelated malignancies, HIV and the aging population |
Q33642185 | Infections and Follicular Lymphoma: is there a Link? |
Q36843283 | Infections and cancer: debate about using vaccines as a cancer control tool |
Q90731772 | Infiltrating CD4 and CD8 lymphocytes in HPV infected uterine cervical milieu |
Q35249205 | Inflammatory response to liver fluke Opisthorchis viverrini in mice depends on host master coregulator MTA1, a marker for parasite-induced cholangiocarcinoma in humans |
Q33762765 | Influence of HIV-1 and/or HIV-2 infection and CD4 count on cervical HPV DNA detection in women from Senegal, West Africa |
Q36970255 | Influence of oxidation and multimerization on the immunogenicity of a thioredoxin-l2 prophylactic papillomavirus vaccine |
Q34192784 | Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study |
Q92585765 | Insertional oncogenesis by HPV70 revealed by multiple genomic analyses in a clinically HPV-negative cervical cancer |
Q28731860 | Insights into SCP/TAPS proteins of liver flukes based on large-scale bioinformatic analyses of sequence datasets |
Q39807848 | Integrating novel primary- and secondary-prevention strategies: the next challenge for cervical cancer control |
Q34360414 | InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions |
Q39090529 | Interaction of HPV E6 oncoproteins with specific proteasomal subunits |
Q36138481 | Interaction of the Human Papillomavirus E6 Oncoprotein with Sorting Nexin 27 Modulates Endocytic Cargo Transport Pathways |
Q85597772 | Interactions between E6AP and E6 proteins from alpha and beta HPV types |
Q59351027 | Interfacing Pathogen Detection with Smartphones for Point-of-Care Applications |
Q39241651 | International trends in anal cancer incidence rates |
Q34989590 | Interplay between DNA repair and inflammation, and the link to cancer |
Q42283899 | Intratypic variants of human papillomavirus type 16 and risk of cervical neoplasia in Taiwan |
Q33682928 | Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types |
Q42650234 | Investigating Canadian parents' HPV vaccine knowledge, attitudes and behaviour: a study protocol for a longitudinal national online survey |
Q40117840 | Investigating the role of human papillomavirus in lung cancer |
Q38833796 | Investigation on oxidative stress of nitric oxide synthase interacting protein from Clonorchis sinensis |
Q34974475 | Invited commentary: multiple human papillomavirus infections and type replacement-anticipating the future after human papillomavirus vaccination |
Q35757333 | Involvement of PSMD10, CDK4, and Tumor Suppressors in Development of Intrahepatic Cholangiocarcinoma of Syrian Golden Hamsters Induced by Clonorchis sinensis and N-Nitrosodimethylamine. |
Q91991673 | Is one dose of human papillomavirus vaccine as effective as three?: A national cohort analysis |
Q52586065 | KSHV induces immunoglobulin rearrangements in mature B lymphocytes. |
Q34417383 | KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies. |
Q33632932 | Kaposi Sarcoma Herpesvirus (KSHV) Latency-Associated Nuclear Antigen (LANA) recruits components of the MRN (Mre11-Rad50-NBS1) repair complex to modulate an innate immune signaling pathway and viral latency |
Q40046587 | Kaposi sarcoma herpesvirus pathogenesis. |
Q38865926 | Kaposi sarcoma trends in Uganda and Zimbabwe: a sustained decline in incidence? |
Q34470355 | Kaposi sarcoma-associated herpesvirus-associated malignancies: epidemiology, pathogenesis, and advances in treatment. |
Q35077642 | Kaposi's sarcoma-associated herpesvirus infection of endothelial cells inhibits neutrophil recruitment through an interleukin-6-dependent mechanism: a new paradigm for viral immune evasion |
Q36155542 | Kaposi's sarcoma-associated herpesvirus inhibits expression and function of endothelial cell major histocompatibility complex class II via suppressor of cytokine signaling 3 |
Q31027665 | Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis |
Q35743733 | Knowledge on HPV Vaccine and Cervical Cancer Facilitates Vaccine Acceptability among School Teachers in Kitui County, Kenya |
Q33853878 | LAMPhimerus: A novel LAMP assay for detecting Amphimerus sp. DNA in human stool samples |
Q87411147 | LGALS3 as a prognostic factor for classical Hodgkin's lymphoma |
Q33781541 | Lack of heterogeneity of HPV16 E7 sequence compared with HPV31 and HPV73 may be related to its unique carcinogenic properties |
Q34753047 | Laser capture microdissection shows HPV11 as both a causal and a coincidental infection in cervical cancer specimens with multiple HPV types |
Q93064860 | Latency and lytic replication in Epstein-Barr virus-associated oncogenesis |
Q38427810 | Latitude gradients for lymphoid neoplasm subtypes in Australia support an association with ultraviolet radiation exposure |
Q34064235 | Lessons from Australia: human papillomavirus is not a major risk factor for esophageal squamous cell carcinoma |
Q40051371 | Lifestyle factors and oncogenic papillomavirus infection in a high-risk male population. |
Q36395656 | Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening |
Q38742752 | Lineage-specific expansion and loss of tyrosinase genes across platyhelminths and their induction profiles in the carcinogenic oriental liver fluke, Clonorchis sinensis. |
Q34209101 | Lineages of oncogenic human papillomavirus types other than type 16 and 18 and risk for cervical intraepithelial neoplasia |
Q38975511 | Liver fluke infection and cholangiocarcinoma: a review |
Q47922162 | Long term variations in erythema effective solar UV at Chilton, UK, from 1991 to 2015. |
Q35768850 | Long-Term Clinical Outcome after Treatment for High-Grade Cervical Lesions: A Retrospective Monoinstitutional Cohort Study |
Q42204957 | Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: a 14-year follow-up of a randomized primary HPV screening trial. |
Q44807462 | Long-term follow-up Helicobacter pylori reinfection rate and its associated factors in Korea |
Q47441530 | Long-term persistence of human papillomavirus in the skin of the glans penis of elderly men above 80 years of age. |
Q35163993 | Long-term persistence of oral human papillomavirus type 16: the HPV Infection in Men (HIM) study |
Q34763988 | Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancer |
Q41620477 | Long-term risk of cervical intraepithelial neoplasia grade 3 or worse according to high-risk human papillomavirus genotype and semi-quantitative viral load among 33,288 women with normal cervical cytology. |
Q35907158 | Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment |
Q35669010 | Longitudinal analysis of carcinogenic human papillomavirus infection and associated cytologic abnormalities in the Guanacaste natural history study: looking ahead to cotesting |
Q33698774 | Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection |
Q45393476 | Loss of Genome Fidelity: Beta HPVs and the DNA Damage Response |
Q54393225 | Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions. |
Q42197987 | Low prevalence of human papillomavirus in head and neck squamous cell carcinoma in Chinese patients |
Q47239227 | Low prevalence of vaccine-type HPV infections in young women following the implementation of a school-based and catch-up vaccination in Quebec, Canada |
Q35974650 | Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3. |
Q54210992 | Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in Guatemala. |
Q35739512 | Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection |
Q51242022 | Lymphoid neoplasm incidence by WHO subtype in Australia 1982-2006. |
Q26740426 | Major parasitic diseases of poverty in mainland China: perspectives for better control |
Q35665795 | Male Circumcision and STI Acquisition in Britain: Evidence from a National Probability Sample Survey |
Q40072730 | Male Partners of Infertile Couples with Seminal Infections of Human Papillomavirus Have Impaired Fertility Parameters. |
Q34552677 | Male circumcision and prevalence of genital human papillomavirus infection in men: a multinational study |
Q35091981 | Male circumcision and the incidence and clearance of genital human papillomavirus (HPV) infection in men: the HPV Infection in men (HIM) cohort study |
Q37843258 | Male infertility: a public health issue caused by sexually transmitted pathogens |
Q38474214 | Malignancies after kidney transplantation: a 40-year single-center experience in Korea |
Q34205793 | MassARRAY spectrometry is more sensitive than PreTect HPV-Proofer and consensus PCR for type-specific detection of high-risk oncogenic human papillomavirus genotypes in cervical cancer |
Q34358742 | Mechanisms of HCV-induced liver cancer: what did we learn from in vitro and animal studies? |
Q42197971 | Meta-analysis of type-specific human papillomavirus prevalence in Iranian women with normal cytology, precancerous cervical lesions and invasive cervical cancer: Implications for screening and vaccination |
Q26999877 | Metagenomics: A new horizon in cancer research |
Q40250983 | Metformin and the incidence of viral associated cancers in patients with type 2 diabetes. |
Q91596225 | Methylation of High-Risk Human Papillomavirus Genomes Are Associated with Cervical Precancer in HIV-Positive Women |
Q37264251 | Methylation of human papillomavirus Type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCR. |
Q64061295 | MiRNA-7-5p Inhibits the Growth and Migration of Hepatoma Cells via Cross-Species Regulation of S-Phase Kinase-Associated Protein 2 |
Q90643326 | MicroRNA Involvement in Signaling Pathways During Viral Infection |
Q42148119 | Mitochondrial haplogroups and control region polymorphisms in Kaposi's sarcoma patients |
Q40382411 | Mitotic control of human papillomavirus genome-containing cells is regulated by the function of the PDZ-binding motif of the E6 oncoprotein |
Q57477151 | Modeling the Transmission Dynamics of Clonorchiasis in Foshan, China |
Q30573204 | Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada |
Q38543395 | Modification of drug delivery to improve antibiotic targeting to the stomach. |
Q52656062 | Molecular Diagnosis of Felis catus Gammaherpesvirus 1 (FcaGHV1) Infection in Cats of Known Retrovirus Status with and without Lymphoma. |
Q61807992 | Molecular Identification and Phylogenetic Analysis of Nuclear rDNA Sequences of Isolates From Human Fecal Samples in Heilongjiang Province, China |
Q30399634 | Molecular and Structural Characterization of the Tegumental 20.6-kDa Protein in Clonorchis sinensis as a Potential Druggable Target |
Q51213476 | Molecular and structural characteristics of multidrug resistance-associated protein 7 in Chinese liver fluke Clonorchis sinensis. |
Q28485368 | Molecular changes in Opisthorchis viverrini (Southeast Asian liver fluke) during the transition from the juvenile to the adult stage |
Q90706883 | Molecular characteristics and induction profiles of hypoxia-inducible factor-1α and other basic helix-loop-helix and Per-Arnt-Sim domain-containing proteins identified in a carcinogenic liver fluke Clonorchis sinensis |
Q39137323 | Molecular characterization of Clonorchis sinensis tetraspanin 2 extracellular loop 2. |
Q34511144 | Molecular characterization of a tetraspanin from the human liver fluke, Opisthorchis viverrini |
Q34394949 | Molecular characterization of an α-N-acetylgalactosaminidase from Clonorchis sinensis |
Q46760732 | Molecular characterization of voltage-gated calcium channel β-subunits of Clonorchis sinensis |
Q27304990 | Molecular cloning and characterization of taurocyamine kinase from Clonorchis sinensis: a candidate chemotherapeutic target |
Q34589241 | Molecular identification, immunolocalization, and characterization of Clonorchis sinensis calmodulin |
Q28070323 | Molecular mechanisms of HPV mediated neoplastic progression |
Q38723429 | Molecular mechanisms of human papillomavirus-related carcinogenesis in head and neck cancer. |
Q90092792 | Molecular mechanisms underlying increased radiosensitivity in human papillomavirus-associated oropharyngeal squamous cell carcinoma |
Q35356381 | Molecular methods and platforms for infectious diseases testing a review of FDA-approved and cleared assays |
Q50091385 | Monitoring the impact of HPV vaccine in males-Considerations and challenges. |
Q94234419 | Mosquitoes, Infectious Diseases, and Cancer: A Connection to Study? |
Q37627688 | Moving forward in HIV-associated cancer. |
Q64256422 | Mucosal and Cutaneous Human Papillomavirus Infections and Cancer Biology |
Q34005902 | Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England |
Q45418018 | Multidrug resistance-associated protein 4 is a bile transporter of Clonorchis sinensis simulated by in silico docking. |
Q37566009 | Multiple HPV infections in female sex workers in Western Kenya: implications for prophylactic vaccines within this sub population. |
Q41710612 | Multiple human papillomavirus infection with or without type 16 and risk of cervical intraepithelial neoplasia among women with cervical cytological abnormalities |
Q33761459 | Multiple recombinant antigens of Clonorchis sinensis for serodiagnosis of human clonorchiasis |
Q34793429 | Multiplex Identification of Human Papillomavirus 16 DNA Integration Sites in Cervical Carcinomas |
Q41689179 | Multiplex PCR assay for the rapid identification of human papillomavirus genotypes 16, 18, 45, 35, 66, 33, 51, 58, and 31 in clinical samples. |
Q31102359 | Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study |
Q92930453 | Multisite HPV infections in the United States (NHANES 2003-2014): An overview and synthesis |
Q38061252 | Mutations of the TP53 gene in adenocarcinoma and squamous cell carcinoma of the cervix: a systematic review |
Q37374081 | NF-κB as a target for oncogenic viruses |
Q27347744 | NHANES 2009-2012 Findings: Association of Sexual Behaviors with Higher Prevalence of Oral Oncogenic Human Papillomavirus Infections in U.S. Men |
Q29248394 | National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Consensus Recommendations for Subsequent Neoplasms |
Q55080397 | Natural History and Prognostic Factors of Cholangiocarcinoma With Spinal Metastasis: A 10-Year Single Center Study. |
Q60916099 | Natural Products Mediated Targeting of Virally Infected Cancer |
Q90134394 | Negative plasma Epstein-Barr virus DNA nasopharyngeal carcinoma in an endemic region and its influence on liquid biopsy screening programmes |
Q92190812 | Neglected Agent Eminent Disease: Linking Human Helminthic Infection, Inflammation, and Malignancy |
Q35985515 | Neutralization of non-vaccine human papillomavirus pseudoviruses from the A7 and A9 species groups by bivalent HPV vaccine sera |
Q42204836 | Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes |
Q28072213 | New Biomedical Technologies and Strategies for Prevention of HIV and Other Sexually Transmitted Infections |
Q33833622 | New HPV16 viral biomarkers to understand the progression of cervical lesions towards cancer |
Q36313296 | New insights into cervical cancer screening. |
Q36880375 | New insights into human papillomavirus-associated head and neck squamous cell carcinoma |
Q39157266 | New locality record for Haplorchoides mehrai and possible interactions with Opisthorchis viverrini metacercariae in cyprinid fishes in Northeast Thailand |
Q35550810 | Next Generation Cancer Protection: The Bivalent HPV Vaccine for Females |
Q36383927 | Next-generation sequencing of cervical DNA detects human papillomavirus types not detected by commercial kits. |
Q93079992 | Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population |
Q39252023 | Nitric oxide-dependent downregulation of BRCA1 expression promotes genetic instability |
Q34756499 | No role for human papillomavirus in esophageal squamous cell carcinoma in China |
Q37838813 | Non-AIDS-Defining Malignancies in Patients with HIV in the HAART Era. |
Q37720028 | Non‑infective occupational risk factors for hepatocellular carcinoma: A review (Review). |
Q95923729 | Novel Forms of Immunomodulation for Cancer Therapy |
Q35689082 | Novel microsphere-based method for detection and typing of 46 mucosal human papillomavirus types |
Q40641957 | Nuclear factor kappa B pathway associated biomarkers in AIDS defining malignancies. |
Q38064057 | Nucleic acid tests for the detection of alpha human papillomaviruses |
Q38216131 | Nucleic acid-based tissue biomarkers of urologic malignancies |
Q44170367 | Occurrence of vaccine and non-vaccine human papillomavirus types in adolescent Finnish females 4 years post-vaccination |
Q36130550 | Oncogenic Human Papillomavirus Infections in 18- to 24-Year-Old Female Online Daters |
Q28743949 | Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos |
Q35250836 | Opisthorchiasis: an overlooked danger |
Q35870248 | Opisthorchis viverrini excretory/secretory products induce toll-like receptor 4 upregulation and production of interleukin 6 and 8 in cholangiocyte |
Q38139812 | Opportunistic infections due to inflammatory bowel disease therapy |
Q37679237 | Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana |
Q35632240 | P16 and Ki-67 expression improves the diagnostic accuracy of cervical lesions but not predict persistent high risk human papillomavirus infection with CIN1. |
Q38607549 | PD-L1 expression correlates with VEGF and microvessel density in patients with uniformly treated classical Hodgkin lymphoma |
Q90616789 | PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18 |
Q34991090 | PDZRN3/LNX3 is a novel target of human papillomavirus type 16 (HPV-16) and HPV-18 E6. |
Q92668951 | Paediatric virology and human papillomaviruses: An update |
Q31114737 | Painless Jaundice Caused by Clonorchis sinensis Infection: A Case Report |
Q31161320 | Papillomavirus genomes associate with BRD4 to replicate at fragile sites in the host genome |
Q43227803 | Papillomaviruses: evolution, Linnaean taxonomy and current nomenclature |
Q28067519 | Parasite Infection, Carcinogenesis and Human Malignancy |
Q35397565 | Parasite infection is associated with Kaposi's sarcoma associated herpesvirus (KSHV) in Ugandan women |
Q42353369 | Parasitology should not be abandoned: data from outpatient parasitological testing in Guangdong, China. |
Q92498448 | Partial Characterization of Two Cathepsin D Family Aspartic Peptidases of Clonorchis sinensis |
Q45353082 | Patterns of cervical coinfection with multiple human papilloma virus types in a screening population in Denmark |
Q34699968 | Patterns of human papillomavirus DNA and antibody positivity in young males and females, suggesting a site-specific natural course of infection. |
Q34971664 | Patterns of human papillomavirus types in multiple infections: an analysis in women and men of the high throughput human papillomavirus monitoring study |
Q37834238 | Patterns of prevalent HPV and STI co-infections and associated factors among HIV-negative young Western Cape, South African women: the EVRI trial |
Q35981334 | Paucity of HPV-Related Head and Neck Cancers (HNC) in Nigeria |
Q49461760 | Performance evaluation of existing immunoassays for Clonorchis sinensis infection in China. |
Q64080031 | Performance of Different Combination Models of High-Risk HPV Genotyping in Triaging Chinese Women With Atypical Squamous Cells of Undetermined Significance |
Q84818275 | Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study |
Q34736619 | Performance of self-collected cervical samples in screening for future precancer using human papillomavirus DNA testing |
Q55531260 | Periodontitis and oral human papillomavirus infection among Hispanic adults. |
Q35223393 | Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer |
Q93161915 | Phosphorylation of Human Papillomavirus Type 16 L2 Contributes to Efficient Virus Infectious Entry |
Q54094196 | Phylogeny and polymorphism in the long control regions E6, E7, and L1 of HPV Type 56 in women from southwest China. |
Q64124680 | Pilot study of markers for high-grade anal dysplasia in a southern cohort from the Women's Interagency HIV Study (WIHS) |
Q92416846 | Pitfalls of commercially available HPV tests in HPV68a detection |
Q39331773 | Pleiotropic cytotoxicity of VacA toxin in host cells and its impact on immunotherapy |
Q37288157 | Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes |
Q57089346 | Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model–Based Analysis |
Q36427407 | Population-based study on the prevalence of and risk factors for human papillomavirus infection in Qujing of Yunnan province, Southwest China |
Q91909387 | Positivity and prevalence of human papillomavirus among a large population of women in southeastern China |
Q39687528 | Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: a cervical cancer screening based study |
Q42209186 | Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening |
Q42272904 | Pre-vaccination seroprevalence of 15 human papillomavirus (HPV) types among women in the population-based Slovenian cervical screening program |
Q35752872 | Pre-vaccination type-specific HPV prevalence in confirmed cervical high grade lesions in the Māori and non-Māori populations in New Zealand |
Q33713347 | Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers |
Q92795372 | Prevalence and Characteristics of hrHPV Infection among 414,540 Women: A Multicenter Study in Central and Eastern China |
Q91922934 | Prevalence and Distribution of Human Papillomavirus Genotypes Among Women in Kinshasa, The Democratic Republic of the Congo |
Q41206464 | Prevalence and concordance of human papillomavirus infection at multiple anatomic sites among HIV-infected women from Chennai, India |
Q37642113 | Prevalence and determinants of high-risk human papillomavirus infection in male genital warts |
Q58616866 | Prevalence and distribution of human papillomavirus genotypes among women with high-grade squamous intraepithelial lesion and invasive cervical cancer in Ganzhou, China |
Q34074208 | Prevalence and molecular epidemiology of human papillomavirus infection in italian women with cervical cytological abnormalities |
Q45323519 | Prevalence and molecular profiling of Epstein Barr virus (EBV) among healthy blood donors from different nationalities in Qatar |
Q47598969 | Prevalence and risk factors associated with high-grade anal squamous intraepithelial lesions (HSIL)-AIN2 and HSIL-AIN3 in homosexual men. |
Q36346755 | Prevalence and risk factors for HPV in HIV-positive young women receiving their first HPV vaccination |
Q35853643 | Prevalence and risk factors for cancer of the uterine cervix among women living in Kinshasa, the Democratic Republic of the Congo: a cross-sectional study |
Q37848169 | Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial |
Q36332181 | Prevalence and risk factors for oncogenic human papillomavirus infections in high-risk mid-adult women |
Q34218871 | Prevalence and risk factors of clonorchiasis among residents of riverside areas in Muju-gun, Jeollabuk-do, Korea |
Q33803206 | Prevalence and risk profile of cervical Human papillomavirus infection in Zhejiang Province, southeast China: a population-based study |
Q50543183 | Prevalence and stability of antibodies to 37 human papillomavirus types--a population-based longitudinal study. |
Q36391662 | Prevalence and type distribution of human papillomavirus in squamous cell carcinoma and intraepithelial neoplasia of the vulva |
Q90370251 | Prevalence and type-specific distribution of human papillomavirus infection among women in mid-western rural, Nepal- A population-based study |
Q38672420 | Prevalence characteristics of cervical human papillomavirus (HPV) genotypes in the Taizhou area, China: a cross-sectional study of 37 967 women from the general population |
Q38974297 | Prevalence of Genital Human Papillomavirus in Males, United States, 2013-2014. |
Q28541777 | Prevalence of HPV 16 and HPV 18 lineages in Galicia, Spain |
Q90438579 | Prevalence of HPV infection among sexually active adolescents and young adults in Brazil: The POP-Brazil Study |
Q38944887 | Prevalence of HPV infection and genotype distribution in women from Africa seeking asylum in Puglia, Italy. |
Q40141459 | Prevalence of Human Papillomavirus Infection in Women in the Autonomous Region of Inner Mongolia: a Population-based Study of a Chinese Ethnic Minority. |
Q40116201 | Prevalence of Human Papillomavirus in Self-Taken Samples from Screening Nonattenders. |
Q38194325 | Prevalence of Human Papillomavirus in endometrial cancer: a systematic review and meta-analysis |
Q38745367 | Prevalence of Human Papillomavirus infection among Chilean women from 2012 to 2016. |
Q49450258 | Prevalence of Specific Types of Human Papiloma Virus in Cervical Intraepithelial Lesions and Cervical Cancer in Macedonian Women. |
Q36257446 | Prevalence of and Associated Risk Factors for High Risk Human Papillomavirus among Sexually Active Women, Swaziland |
Q40862790 | Prevalence of and Risk Factors for Anal Oncogenic Human Papillomavirus Infection Among HIV-Infected Women in France in the Combination Antiretroviral Therapy Era. |
Q38944257 | Prevalence of anogenital HPV infection, related disease and risk factors among HIV-infected men in inner-city Johannesburg, South Africa: baseline findings from a cohort study |
Q35768546 | Prevalence of esophageal squamous papilloma (ESP) and associated cancer in northeastern France |
Q45251131 | Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006. |
Q45342236 | Prevalence of genotype-specific human papillomavirus infection and cervical neoplasia in Taiwan: a community-based survey of 10,602 women |
Q30890822 | Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial |
Q37848950 | Prevalence of human papillomavirus (HPV) infections in sexually active adolescents and young women in England, prior to widespread HPV immunisation |
Q34637954 | Prevalence of human papillomavirus in 5,072 consecutive cervical SurePath samples evaluated with the Roche cobas HPV real-time PCR assay |
Q34061684 | Prevalence of human papillomavirus in adolescent girls before reported sexual debut |
Q58280163 | Prevalence of human papillomavirus in women with invasive cervical carcinoma by HIV status in Kenya and South Africa |
Q39475692 | Prevalence of human papillomavirus infection among women presenting for cervical cancer screening in Chile, 2014-2015. |
Q98289239 | Prevalence of human papillomavirus infection and type distribution among Uyghur females in Xinjiang, northwest China |
Q64237318 | Prevalence of human papillomavirus infection of 65,613 women in East China |
Q36865275 | Prevalence of human papillomavirus types and variants and p16(INK4a) expression in head and neck squamous cells carcinomas in São Paulo, Brazil. |
Q47141407 | Prevalence of oncogenic human papillomavirus genotypes in patients diagnosed with anogenital malignancies in Botswana |
Q38773959 | Prevalence of oral human papillomavirus by vaccination status among young adults (18-30years old). |
Q37454986 | Prevalence of papillomavirus in Brazil: a systematic review protocol |
Q35879158 | Prevalence of type-specific HPV among female university students from northern Brazil |
Q54223962 | Prevalence, incidence and correlates of low risk HPV infection and anogenital warts in a cohort of women living with HIV in Burkina Faso and South Africa. |
Q37847698 | Prevalence, incidence and persistence of genital HPV infections in a large cohort of sexually active young women in the Netherlands |
Q30566680 | Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal) |
Q35660411 | Prevalent high-risk HPV infection and vaginal microbiota in Nigerian women. |
Q28255126 | Preventable exposures associated with human cancers |
Q26777318 | Prevention of infection-related cancers in the WHO Western Pacific Region |
Q36736361 | Primary B Lymphocytes Infected with Kaposi's Sarcoma-Associated Herpesvirus Can Be Expanded In Vitro and Are Recognized by LANA-Specific CD4+ T Cells |
Q92647805 | Primary Infectious Mononucleosis Masquerading as Post-operative Fever in a Young Patient with Cemento-ossifying Fibroma of the Skull Base |
Q37912228 | Primary prophylactic human papillomavirus vaccination programs: future perspective on global impact |
Q35203306 | Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology |
Q26825488 | Probiotics against neoplastic transformation of gastric mucosa: effects on cell proliferation and polyamine metabolism |
Q36066974 | Prognostic significance of peroxiredoxin 1 and ezrin-radixin-moesin-binding phosphoprotein 50 in cholangiocarcinoma |
Q54298531 | Prognostic value of pretreatment ¹⁸F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma. |
Q53245652 | Programmed death 1 expression in the peritumoral microenvironment is associated with a poorer prognosis in classical Hodgkin lymphoma. |
Q90383582 | Promutagenicity of 8-Chloroguanine, A Major Inflammation-Induced Halogenated DNA Lesion |
Q39328580 | Proof-of-principle study of a novel cervical screening and triage strategy: Computer-analyzed cytology to decide which HPV-positive women are likely to have ≥CIN2. |
Q24202048 | Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors |
Q24235373 | Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors |
Q54217505 | Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. |
Q47210863 | Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. |
Q42436631 | Prospective study of genital human papillomaviruses and nonmelanoma skin cancer |
Q33759930 | Prospects for prevention of HPV-driven oropharynx cancer |
Q38819671 | Proteomic identification of potential biomarkers for cervical squamous cell carcinoma and human papillomavirus infection |
Q38151763 | Proteomics strategies to analyze HPV-transformed cells: relevance to cervical cancer. |
Q34254009 | Proteomics-based identification of α-enolase as a potential prognostic marker in cholangiocarcinoma |
Q42285579 | Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males |
Q60907824 | Quantification of HPV16 E6/E7 mRNA Spliced Isoforms Viral Load as a Novel Diagnostic Tool for Improving Cervical Cancer Screening |
Q35235162 | Quantitative DNA methylation analysis of candidate genes in cervical cancer |
Q35834013 | RNA Binding Proteins that Control Human Papillomavirus Gene Expression |
Q35133671 | RNA-Seq reveals infection-induced gene expression changes in the snail intermediate host of the carcinogenic liver fluke, Opisthorchis viverrini |
Q54974939 | RSF-1 overexpression determines cancer progression and drug resistance in cervical cancer. |
Q35075414 | Randomization modeling to ascertain clustering patterns of human papillomavirus types detected in cervicovaginal samples in the United States |
Q35649341 | Rapid detection of Opisthorchis viverrini copro-DNA using loop-mediated isothermal amplification (LAMP). |
Q40348516 | Rates and determinants of incidence and clearance of cervical HPV genotypes among HIV-seropositive women in Pune, India. |
Q34137915 | Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project |
Q35906815 | Reactive species and DNA damage in chronic inflammation: reconciling chemical mechanisms and biological fates |
Q38364089 | Recalcitrant plantar warts during azathioprine therapy for Crohn's disease |
Q39034549 | Recent advances in proteomic applications for schistosomiasis research: potential clinical impact |
Q36901045 | Recent cancer incidence trends in an observational clinical cohort of HIV-infected patients in the US, 2000 to 2011 |
Q37375588 | Record linkage to correct under-ascertainment of cancers in HIV cohorts: The Sinikithemba HIV clinic linkage project |
Q88813826 | Recurrence of Genital Infections With 9 Human Papillomavirus (HPV) Vaccine Types (6, 11, 16, 18, 31, 33, 45, 52, and 58) Among Men in the HPV Infection in Men (HIM) Study |
Q37503936 | Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England |
Q38064056 | Reframing cervical cancer prevention. Expanding the field towards prevention of human papillomavirus infections and related diseases |
Q57475469 | Regulation of HPV transcription |
Q38087843 | Regulation of human papillomavirus gene expression by splicing and polyadenylation |
Q36370394 | Relationship between CK19 expression, deregulation of normal keratinocyte differentiation pattern and high risk-human papilloma virus infection in oral and oropharyngeal squamous cell carcinoma |
Q36584268 | Relationship between Metabolic Syndrome and History of Cervical Cancer among a US National Population |
Q57877211 | Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies |
Q27023448 | Relationships between lymphomas linked to hepatitis C virus infection and their microenvironment |
Q64070590 | Repeated praziquantel treatment and Opisthorchis viverrini infection: a population-based cross-sectional study in northeast Thailand |
Q36558983 | Reproducibility of linear array for human papillomavirus genotyping |
Q37995108 | Review: antibodies to cutaneous human papillomaviruses. |
Q37233963 | Risk Factors for Oral Human Papillomavirus Infection in Healthy Individuals: A Systematic Review and Meta-Analysis |
Q33728067 | Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women |
Q35117163 | Risk factors for high-risk and multi-type Human Papillomavirus infections among women in Ho Chi Minh City, Vietnam: a cross-sectional study. |
Q33636055 | Risk mapping of clonorchiasis in the People's Republic of China: A systematic review and Bayesian geostatistical analysis |
Q40412473 | Risk of Delayed Human Papillomavirus Vaccination in Inner-City Adolescent Women |
Q88541577 | Risk of HPV-16/18 Infections and Associated Cervical Abnormalities in Women Seropositive for Naturally Acquired Antibodies: Pooled Analysis Based on Control Arms of Two Large Clinical Trials |
Q40198005 | Risk of Onset of Hematological Malignancies in Patients Infected with the Hepatitis B Virus: Results from a Large-Scale Retrospective Cohort Study in China |
Q35204230 | Risk of cancer among HIV-infected patients from a population-based nested case-control study: implications for cancer prevention |
Q45166430 | Risk of cancer among workers exposed to trichloroethylene: analysis of three Nordic cohort studies |
Q64127196 | Risk of cervical dysplasia among human papillomavirus-infected women in Korea: a multicenter prospective study |
Q36567658 | Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection |
Q36941977 | Risk of precancer determined by HPV genotype combinations in women with minor cytologic abnormalities |
Q40889610 | Risk of virus-associated cancer in female arthritis patients treated with biological DMARDs-a cohort study |
Q91397020 | Risk prediction of cervical abnormalities: The value of sociodemographic and lifestyle factors in addition to HPV status |
Q57176933 | Role of Epstein-Barr Virus in the Pathogenesis of Head and Neck Cancers and Its Potential as an Immunotherapeutic Target |
Q55338587 | Role of Pattern Recognition Receptors in KSHV Infection. |
Q30299997 | Role of histological findings and pathologic diagnosis for detection of human papillomavirus infection in men |
Q38183454 | Role of inflammation in HIV-1 disease progression and prognosis |
Q38952814 | Role of socio-cultural and economic factors in cyprinid fish distribution networks and consumption in Lawa Lake region, Northeast Thailand: Novel perspectives on Opisthorchis viverrini transmission dynamics |
Q55613070 | Role of the DNA Damage Response in Human Papillomavirus RNA Splicing and Polyadenylation. |
Q35403714 | Roles of the immune system in skin cancer. |
Q33648719 | S100A7 promotes the migration, invasion and metastasis of human cervical cancer cells through epithelial-mesenchymal transition |
Q34763466 | Schistosome and liver fluke derived catechol-estrogens and helminth associated cancers |
Q58750202 | Schistosomiasis |
Q34951637 | Schistosomiasis and cancer in egypt: review |
Q33925782 | Secreted cysteine proteases of the carcinogenic liver fluke, Opisthorchis viverrini: regulation of cathepsin F activation by autocatalysis and trans-processing by cathepsin B |
Q38390283 | Secretomic analysis of extracellular vesicles originating from Polyomavirus-negative and Polyomavirus-positive merkel cell carcinoma cell lines |
Q54229599 | Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs. |
Q36120539 | Self-reported history of infections and the risk of non-Hodgkin lymphoma: an InterLymph pooled analysis |
Q35098354 | Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter |
Q44435078 | Sequence analysis and characterization of pyruvate kinase from Clonorchis sinensis, a 53.1-kDa homopentamer, implicated immune protective efficacy against clonorchiasis |
Q28543067 | Sequence analysis and molecular characterization of Clonorchis sinensis hexokinase, an unusual trimeric 50-kDa glucose-6-phosphate-sensitive allosteric enzyme |
Q33952360 | Sequence imputation of HPV16 genomes for genetic association studies |
Q34602424 | Sequence variation analysis of HPV-18 isolates in southwest China |
Q51416546 | Sequencing analysis of HPV-other type on an HPV DNA chip. |
Q40589093 | Sequential Acquisition of Anal Human Papillomavirus (HPV) Infection Following Genital Infection Among Men Who Have Sex With Women: The HPV Infection in Men (HIM) Study |
Q53430838 | Seroprevalence of HPV 6, 11, 16 and 18 and correlates of exposure in unvaccinated women aged 16-64 years in Puerto Rico. |
Q37225559 | Serum Helicobacter pylori FliD antibody and the risk of gastric cancer |
Q57284128 | Short half-life of HPV16 E6 and E7 mRNAs sensitizes HPV16-positive tonsillar cancer cell line HN26 to DNA-damaging drugs |
Q36116209 | Short-term natural history of high-risk human papillomavirus infection in mid-adult women sampled monthly |
Q51558156 | Short-term type-specific HPV persistence and its predictors in an asymptomatic general female population in Zhejiang, China. |
Q38370778 | Signaling pathways in HPV-associated cancers and therapeutic implications. |
Q41028798 | Simultaneous detection of human papillomavirus integration and c-MYC gene amplification in cervical lesions: an emerging marker for the risk to progression |
Q42237432 | Single human papillomavirus 16 or 52 infection and later cytological findings in Japanese women with NILM or ASC-US. |
Q91610417 | Single-Domain Antibodies Represent Novel Alternatives to Monoclonal Antibodies as Targeting Agents against the Human Papillomavirus 16 E6 Protein |
Q33712114 | Six-month incidence and persistence of oral HPV infection in HIV-negative and HIV-infected men who have sex with men. |
Q35463694 | Six-month incidence, persistence, and factors associated with persistence of anal human papillomavirus in men: the HPV in men study |
Q30238649 | Skin Cancer: Epidemiology, Disease Burden, Pathophysiology, Diagnosis, and Therapeutic Approaches |
Q40877866 | Space-time clustering of childhood cancers in Switzerland: A nationwide study |
Q35680785 | Specific diagnosis of Opisthorchis viverrini using loop-mediated isothermal amplification (LAMP) targeting parasite microsatellites |
Q35336871 | Specific genotypes of human papillomavirus in 125 high-grade squamous lesions and invasive cervical cancer cases from Congolese women |
Q35848186 | Spectrum of cancer risk among US solid organ transplant recipients |
Q34064264 | Spectrum of cancer risk late after AIDS onset in the United States. |
Q39139279 | Splicing and Polyadenylation of Human Papillomavirus Type 16 mRNAs. |
Q39238185 | Stage-specific expression, immunolocalization of Clonorchis sinensis lysophospholipase and its potential role in hepatic fibrosis |
Q47554428 | Strengthening the case for gender-neutral and the nonavalent HPV vaccine |
Q57286493 | Structural Analysis of an Epitope Candidate of Triosephosphate Isomerase in Opisthorchis viverrini |
Q41738958 | Structural properties of a viral orthologue of cellular CD200 protein: KSHV vOX2. |
Q35711258 | Subpathway Analysis based on Signaling-Pathway Impact Analysis of Signaling Pathway |
Q37211860 | Subtype distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia stages 2 and 3 in Botswana |
Q39254514 | Subverting Host Cell P21-Activated Kinase: A Case of Convergent Evolution across Pathogens |
Q37528882 | Suppression of HPV-16 late L1 5'-splice site SD3632 by binding of hnRNP D proteins and hnRNP A2/B1 to upstream AUAGUA RNA motifs |
Q34778995 | Suppression of Ov-grn-1 encoding granulin of Opisthorchis viverrini inhibits proliferation of biliary epithelial cells |
Q42196341 | Suppression of antigen-specific T cell responses by the Kaposi's sarcoma-associated herpesvirus viral OX2 protein and its cellular orthologue, CD200. |
Q48042695 | Surveillance and diagnosis of zoonotic foodborne parasites. |
Q30884881 | Surveillance of human papilloma virus using reference laboratory data for the purpose of evaluating vaccine impact |
Q39144897 | Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women |
Q35182177 | Switch from cytology-based to human papillomavirus test-based cervical screening: implications for colposcopy |
Q53808018 | Systematic review of racial disparities in human papillomavirus-associated anal dysplasia and anal cancer among men who have sex with men. |
Q34239911 | TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix |
Q35795380 | Targeted therapy for Epstein-Barr virus-associated gastric carcinoma using low-dose gemcitabine-induced lytic activation |
Q55439768 | The DNA damage response activates HPV16 late gene expression at the level of RNA processing. |
Q34246710 | The DNA damage response in viral-induced cellular transformation |
Q89577993 | The Detection and Association of Canine Papillomavirus with Benign and Malignant Skin Lesions in Dogs |
Q35850058 | The Dynamics of Treg/Th17 and the Imbalance of Treg/Th17 in Clonorchis sinensis-Infected Mice |
Q36094880 | The Effect of Cryotherapy on Human Papillomavirus Clearance Among HIV-Positive Women in Lusaka, Zambia |
Q90386779 | The Effect of Interrupted/Deferred Antiretroviral Therapy on Disease Risk: A SMART and START Combined Analysis |
Q97569962 | The Efficiency of Type-Specific High-Risk Human Papillomavirus Models in the Triage of Women with Atypical Squamous Cells of Undetermined Significance |
Q35895297 | The Human Papillomavirus E6 PDZ Binding Motif: From Life Cycle to Malignancy |
Q36603938 | The Incidence of Human Papillomavirus in Tanzanian Adolescent Girls Before Reported Sexual Debut |
Q50042026 | The Intersection of HPV Epidemiology, Genomics and Mechanistic Studies of HPV-Mediated Carcinogenesis. |
Q54980026 | The MRE11-RAD50-NBS1 Complex Conducts the Orchestration of Damage Signaling and Outcomes to Stress in DNA Replication and Repair. |
Q33924064 | The Opisthorchis viverrini genome provides insights into life in the bile duct |
Q40366431 | The PTPN14 Tumor Suppressor Is a Degradation Target of Human Papillomavirus E7. |
Q36173887 | The PapilloCheck Assay for Detection of High-Grade Cervical Intraepithelial Neoplasia |
Q30574549 | The Papillomavirus Episteme: a central resource for papillomavirus sequence data and analysis |
Q90469341 | The Prevalence of HPV Genotypes in Iranian Population: An Update |
Q93167108 | The Role of Beta HPV Types and HPV-Associated Inflammatory Processes in Cutaneous Squamous Cell Carcinoma |
Q36029632 | The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test |
Q59133892 | The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor Epithelium |
Q46142571 | The Role of Type 2 Diabetes for the Development of Pathogen-Associated Cancers in the Face of the HIV/AIDS Epidemic. |
Q53175931 | The Role of miRNAs in Virus-Mediated Oncogenesis. |
Q36243929 | The Spectrum of Malignancies among Adult HIV Cohort in Poland between 1995 and 2012: A Retrospective Analysis of 288 Cases |
Q40270627 | The VPS4 component of the ESCRT machinery plays an essential role in HPV infectious entry and capsid disassembly |
Q38606461 | The Value of Partial HPV Genotyping After Conization of Cervical Dysplasias |
Q92525961 | The association between body mass index and anal canal human papillomavirus prevalence and persistence: the HIM study |
Q39604512 | The association between cigarette smoking and non-Hodgkin lymphoid neoplasms in a large US cohort study |
Q38064068 | The biology and life-cycle of human papillomaviruses. |
Q91841593 | The burden of 14 hr-HPV genotypes in women attending routine cervical cancer screening in 20 states of Mexico: a cross-sectional study |
Q50544836 | The burden of HPV associated cancers in two regions in Nigeria 2012-2014. |
Q40277632 | The burden of HPV-related diseases in Italy, 2001-12. |
Q64068476 | The burden of cancers associated with HIV in the South African public health sector, 2004-2014: a record linkage study |
Q37095409 | The carcinogenic liver fluke Opisthorchis viverrini is a reservoir for species of Helicobacter |
Q28546051 | The chemopotential effect of Annona muricata leaves against azoxymethane-induced colonic aberrant crypt foci in rats and the apoptotic effect of Acetogenin Annomuricin E in HT-29 cells: a bioassay-guided approach |
Q35588255 | The clinical meaning of a cervical intraepithelial neoplasia grade 1 biopsy |
Q40957119 | The clinical performance of primary HPV screening, primary HPV screening plus cytology cotesting, and cytology alone at a tertiary care hospital |
Q89540799 | The contribution of Latin American research to HPV epidemiology and natural history knowledge |
Q27676606 | The crystal structure of the DNA-binding domain of vIRF-1 from the oncogenic KSHV reveals a conserved fold for DNA binding and reinforces its role as a transcription factor |
Q38168923 | The current position and the future perspectives of cervical cancer screening |
Q90385101 | The current status of immunotherapy for cervical cancer |
Q28247216 | The current status of opisthorchiasis and clonorchiasis in the Mekong Basin |
Q34788039 | The diversity of human papillomavirus infection among human immunodeficiency virus-infected women in Yunnan, China. |
Q57211146 | The economic burden of human papillomavirus infection-associated diseases in the Republic of Korea, 2002-2015 |
Q34543764 | The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600) |
Q96638637 | The effects of temperature and salinity on the longevity of Opisthorchis viverrini cercariae: a climate change concern |
Q34522052 | The epidemiology of oral HPV infection among a multinational sample of healthy men |
Q37202940 | The evolving definition of carcinogenic human papillomavirus |
Q35085603 | The expression dynamics of transforming growth factor-β/Smad signaling in the liver fibrosis experimentally caused by Clonorchis sinensis |
Q36338867 | The global cancer epidemic: opportunities for Canada in low- and middle-income countries |
Q37008480 | The global epidemiology of clonorchiasis and its relation with cholangiocarcinoma |
Q42238657 | The human papillomavirus (HPV) E6 oncoproteins promotes nuclear localization of active caspase 8. |
Q36973683 | The human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter |
Q33718690 | The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents |
Q51757996 | The impact of oxidative DNA damage and stress on telomere homeostasis. |
Q40364959 | The impact of sexual behavior on oral HPV infections in young unvaccinated adults |
Q54262451 | The implications of male human papilloma virus infection in couples seeking assisted reproduction technologies. |
Q47575035 | The importance of HPV16 in anal cancer prevention |
Q36370353 | The importance of blood-borne viruses in elevated cancer risk among opioid-dependent people: a population-based cohort study |
Q41745967 | The increased detection of cervical intraepithelial neoplasia when using a second biopsy at colposcopy |
Q37781463 | The increasing clinical relevance of human papillomavirus type 16 (HPV-16) infection in oropharyngeal cancer |
Q54213834 | The interplay between alcohol consumption, oral hygiene, ALDH2 and ADH1B in the risk of head and neck cancer. |
Q92684202 | The landscape of transcription initiation across latent and lytic KSHV genomes |
Q89556854 | The landscape of viral associations in human cancers |
Q35074527 | The metastasis-associated protein-1 gene encodes a host permissive factor for schistosomiasis, a leading global cause of inflammation and cancer |
Q36049037 | The natural history of genital human papillomavirus among HIV-negative men having sex with men and men having sex with women |
Q46112576 | The presence of Merkel cell polyomavirus is associated with deregulated expression of BRAF and Bcl-2 genes in non-small cell lung cancer. |
Q41688107 | The presence of betapapillomavirus antibodies around transplantation predicts the development of keratinocyte carcinoma in organ transplant recipients: a cohort study |
Q90418272 | The prevalence and genotype distribution of human papillomaviruses among women in Taizhou, China |
Q40291505 | The prevalence of HPV infections in HPV-vaccinated women from the general population. |
Q35226408 | The prevalence of genital HPV and factors associated with oncogenic HPV among men having sex with men and men having sex with women and men: the HIM study |
Q37056980 | The prevalence of human papillomavirus and its impact on cervical dysplasia in Northern Canada |
Q92217999 | The prevalence, trends, and geographical distribution of human papillomavirus infection in China: The pooled analysis of 1.7 million women |
Q35857515 | The prevention of infection-associated cancers |
Q48152896 | The rediscovery of H. pylori bacteria in the gastric mucosa by Robin Warren, and implications of this finding for human biology and disease |
Q57049696 | The relationship between anogenital HPV types and incident HIV infection among men who have sex with men and transgender women in Lima, Peru: Findings from a prospective cohort study |
Q37951412 | The role of alcohol dehydrogenase genes in head and neck cancers: a systematic review and meta-analysis of ADH1B and ADH1C. |
Q37635138 | The role of monogamy and duration of heterosexual relationships in human papillomavirus transmission |
Q39134383 | The role of protein kinase A regulation of the E6 PDZ-binding domain during the differentiation-dependent life cycle of human papillomavirus type 18. |
Q92382294 | The role of the gastric bacterial microbiome in gastric cancer: Helicobacter pylori and beyond |
Q37359553 | The sero-epidemiology of human papillomavirus among Caucasian transplant recipients in the UK. |
Q37921427 | The socioeconomic burden of parasitic zoonoses: global trends |
Q44698801 | The state of cancer epidemiology curricula in postgraduate schools worldwide |
Q92105680 | The supernatant of cervical carcinoma cells lines induces a decrease in phosphorylation of STAT-1 and NF-κB transcription factors associated with changes in profiles of cytokines and growth factors in macrophages derived from U937 cells |
Q28542937 | The transcription map of human papillomavirus type 18 during genome replication in U2OS cells |
Q35826752 | Therapeutic Vaccine Strategies against Human Papillomavirus |
Q36998862 | Time to tackle clonorchiasis in China |
Q34453484 | Tobacco consumption and genetic susceptibility to nasopharyngeal carcinoma (NPC) in Thailand |
Q41876296 | Toward a general evolutionary theory of oncogenesis |
Q34432763 | Toward integrated opisthorchiasis control in northeast Thailand: the Lawa project |
Q34105253 | Tracing of the Bile-chemotactic migration of juvenile Clonorchis sinensis in rabbits by PET-CT. |
Q93061196 | Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter |
Q33872079 | Transcriptome sequencing demonstrates that human papillomavirus is not active in cutaneous squamous cell carcinoma |
Q64128607 | Transforming properties of ovine papillomaviruses E6 and E7 oncogenes |
Q39356598 | Transmission between Archaic and Modern Human Ancestors during the Evolution of the Oncogenic Human Papillomavirus 16. |
Q55246604 | Treatment de-escalation for HPV-driven oropharyngeal cancer: Where do we stand? |
Q27312453 | Trends in HPV cervical and seroprevalence and associations between oral and genital infection and serum antibodies in NHANES 2003-2012 |
Q58709291 | Trends in Human Papillomavirus-Associated Cancers - United States, 1999-2015 |
Q35048890 | Trends in prevalence of clonorchiasis among patients in Heilongjiang province, Northeast China (2009-2012): implications for monitoring and control |
Q38824019 | Triage of high-risk HPV positive women in cervical cancer screening. |
Q53302283 | Triage of women with atypical squamous cells of undetermined significance (ASC-US): results of an Italian multicentric study. |
Q39484719 | Tribendimidine: an alternative anthelmintic for liver flukes? |
Q42736270 | Tumour-infiltrating lymphocytes in the risk stratification of squamous cell carcinoma of the head and neck |
Q34986850 | Twelve-month incidence and clearance of oral HPV infection in HIV-negative and HIV-infected men who have sex with men: the H2M cohort study |
Q39040989 | Type-dependent association between risk of cervical intraepithelial neoplasia and viral load of oncogenic human papillomavirus types other than types 16 and 18. |
Q41655617 | Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisation. |
Q58694440 | Type-specific high-risk human papillomavirus viral load as a viable triage indicator for high-grade squamous intraepithelial lesion: a nested case–control study |
Q54961163 | Type-specific human papillomavirus infections and Pap test findings in Inuit and non-Inuit women in Nunavut, Canada. |
Q38635196 | Type-specific human papillomavirus prevalence in cervical intraepithelial neoplasia and cancer in Iran. |
Q34604698 | Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand |
Q36631402 | Type-specific prevalence of human papillomavirus in women screened for cervical cancer in Labrador, Canada |
Q36817074 | US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines |
Q38133612 | Understanding HPV tests and their appropriate applications |
Q37088015 | Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines |
Q34141644 | Uneven distribution of human papillomavirus 16 in cervical carcinoma in situ and squamous cell carcinoma in older females: A retrospective database study. |
Q54406456 | Unique variants of human papillomavirus genotypes 52 and 58 and risk of cervical neoplasia. |
Q21092288 | Unlocking the transcriptomes of two carcinogenic parasites, Clonorchis sinensis and Opisthorchis viverrini |
Q42227506 | Untypable human papillomavirus infection and risk of cervical intraepithelial neoplasia among women with abnormal cervical cytology |
Q55235014 | Unusual and unique distribution of anal high-risk human papillomavirus (HR-HPV) among men who have sex with men living in the Central African Republic. |
Q37085618 | Up-regulation of annexin A2 in cholangiocarcinoma caused by Opisthorchis viverrini and its implication as a prognostic marker |
Q35036066 | Updating the PGMY primers and probes for improved detection of HPV68a: validation of version 2 of the PGMY-CHUV assay |
Q54252809 | Updating the epidemiological transition model. |
Q59349302 | Upsetting the Balance: When Viruses Manipulate Cell Polarity Control |
Q28539012 | Urinary estrogen metabolites and self-reported infertility in women infected with Schistosoma haematobium |
Q40853468 | Use of Cytology, E6/E7 mRNA, and p16INK4a-Ki-67 to Define the Management of Human Papillomavirus (HPV)-Positive Women in Cervical Cancer Screening |
Q38231273 | Usefulness, methods and rationale of lymph nodes HPV-DNA investigation in estimating risk of early stage cervical cancer recurrence: a systematic literature review |
Q36743080 | Vaccination against HPV-Associated Neoplasias: Recommendations from the Current S3 Guideline of the HPV Management Forum of the Paul-Ehrlich Society - AWMF Guidelines, Registry No. 082-002 (short version), valid until Dec. 31st, 2018 |
Q36128894 | Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction |
Q39759678 | Vaginal high-risk human papillomavirus infection in a cross-sectional study among women of six different ethnicities in Amsterdam, the Netherlands: the HELIUS study. |
Q60919995 | Validation of Multiplex Serology for human hepatitis viruses B and C, human T-lymphotropic virus 1 and Toxoplasma gondii |
Q37558791 | Validation of an HPV16-mediated carcinogenesis mouse model. |
Q92617082 | Variant sublineages of human papillomavirus type 16 predispose women to persistent infection characterized by a sequence analysis of the E6, L1, and LCR regions |
Q40696460 | Variant-specific persistence of infections with human papillomavirus Types 31, 33, 45, 56 and 58 and risk of cervical intraepithelial neoplasia |
Q30749748 | Variation in Cancer Incidence among Patients with ESRD during Kidney Function and Nonfunction Intervals |
Q44604599 | Vascular endothelial growth factor (VEGF) gene polymorphisms and risk of head and neck cancer: a meta-analysis involving 2,444 individuals |
Q64137499 | Venom allergen-like protein 28 in Clonorchis sinensis: four epitopes on its surface and the potential role of Cys124 for its conformational stability |
Q26770053 | Viral Interactions with PDZ Domain-Containing Proteins-An Oncogenic Trait? |
Q47571734 | Viral Oncology: Molecular Biology and Pathogenesis |
Q42245758 | Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer |
Q38220140 | Viral causes of feline lymphoma: retroviruses and beyond |
Q51489547 | Viral colonization in exhaled breath condensate of lung cancer patients: Possible role of EBV and CMV. |
Q37681282 | Viral epigenomes in human tumorigenesis. |
Q38870478 | Viral inhibitors of NKG2D ligands for tumor surveillance. |
Q37626453 | Viral load and short-term natural history of type-specific oncogenic human papillomavirus infections in a high-risk cohort of midadult women |
Q37854816 | Viral oncogenesis and its role in nonmelanoma skin cancer |
Q41925619 | Viral oncoproteins and ubiquitination: accessing a cellular toolbox for modifying protein function |
Q24607716 | Vironome of Kaposi sarcoma associated herpesvirus-inflammatory cytokine syndrome in an AIDS patient reveals co-infection of human herpesvirus 8 and human herpesvirus 6A |
Q37798008 | Virus-like particles in vaccine development. |
Q34567612 | Viruses and human cancer: from detection to causality |
Q40070529 | Viruses in cancers among the immunosuppressed. |
Q58786822 | Visual and modular detection of pathogen nucleic acids with enzyme-DNA molecular complexes |
Q28678670 | Water-related parasitic diseases in China |
Q35224544 | What lies within: coinfections and immunity |
Q36255302 | Whole Genome Amplification and Reduced-Representation Genome Sequencing of Schistosoma japonicum Miracidia. |
Q22122084 | Whole-genome sequence of Schistosoma haematobium |
Q61811419 | Whole-genome sequence of the bovine blood fluke Schistosoma bovis supports interspecific hybridization with S. haematobium |
Q37811898 | Why do viruses cause cancer? Highlights of the first century of human tumour virology |
Q47429122 | Zone-size nonuniformity of 18F-FDG PET regional textural features predicts survival in patients with oropharyngeal cancer. |
Q82646885 | [Biology of epidermodysplasia verruciformis-associated HPV] |
Q85738539 | [Proven and new methods in the treatment of genital warts] |
Q47635199 | hnRNP L controls HPV16 RNA polyadenylation and splicing in an Akt kinase-dependent manner |
Q34979227 | hr-HPV testing in the follow-up of women with cytological abnormalities and negative colposcopy |
Q58378066 | p16/Ki-67 dual staining in cervico-vaginal cytology: Correlation with histology, Human Papillomavirus detection and genotyping in women undergoing colposcopy |
Q35665960 | p53 degradation activity, expression, and subcellular localization of E6 proteins from 29 human papillomavirus genotypes |
Search more.